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Abstract 
 
 
 
MECHANISMS ASSOCIATED WITH AGING AND AGE-RELATED DISEASE IN 
DROSOPHILA 
 
Melanie Ann Jones, B.S. 
 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University.  
 
 
Virginia Commonwealth University, 2010.  
 
 
Director: Dr. Michael Grotewiel 
Associate Professor, Department of Human and Molecular Genetics 
 
 
 
Aging is an intrinsic process that is independent of obvious disease.  In contrast to normal aging, 
age-related diseases are conditions that typically manifest at advanced ages, are associated with 
explicit pathology and cause disability and premature death.  We used Drosophila as a model to 
investigate the molecular-genetic mechanisms associated with aging and age-related disease.  
Age-related locomotor impairment (ARLI) is a serious condition for the elderly and greatly 
impacts their quality of life.  Toward identifying genes and mechanisms that influence ARLI, we 
performed a forward genetic screen using Drosophila mutants.  This screen identified a loss of 
function mutant in PDK1, a component of the insulin signaling pathway.  Additional loss of 
function mutants in the insulin signaling pathway genes PI3K Dp110, and AKT also delayed 
ARLI.  These results suggest a role for insulin signaling in ARLI.  Wolfram Syndrome (WFS) is 
 xiii
a progressive neurodegenerative disease that is caused by mutations in the genes WFS1 and 
CISD2.  The function of CISD2, the most recently identified gene has not been fully resolved.  
We used RNAi to knockdown wfs2, the fly ortholog of CISD2 to identify genes and pathways 
associated with wfs2 that will provide insight into the normal function of this gene.  Through a 
targeted genetic screen in the Drosophila eye we identified that wfs2 interacts with two 
lysosomal storage disease genes PPT1 and CLN3.  These results suggest that WFS and 
lysosomal storage diseases may be influenced by common molecular-genetic mechanisms.  
Furthermore, wfs2 may play a role in the neurodegenerative pathways associated with lysosomal 
storage disease.  Oxidative stress is associated with aging and age-related disease.  To identify 
genes that can protect against endogenous oxidative stress we performed a candidate suppressor 
screen.  This screen revealed that expression of wild-type Ataxin-3 suppressed the short lifespan 
of Sod2 knockdown flies.  The ubiquitin associated function of Ataxin-3 was determined to be 
important for this suppression.  Interestingly, Ataxin-3 expression also extended the short 
lifespan due to knockdown of thioredoxin reductase in muscle.  These results suggest that 
Ataxin-3 expression may play a protective role against enhanced endogenous oxidative stress due 
to reduced function of a number of antioxidant enzymes.   
 
 
 
 
 
 
 xiv
Aging, Age-Related Disease, and the Drosophila Model 
 
 
1.  Aging and age-related disease in humans 
 
Aging is an intrinsic process that is independent of obvious disease.  Aging results in reduced 
reproduction and an increased risk of death (Finch et al., 1990).  Functional senescence is the 
progressive age-dependent decline in function and is a fundamental feature of aging (Arking, 
1998).  Functional senescence manifests as defects in behavior, reproduction, cardiac function, 
and immune system function (Lakatta, 1993; Burns, 2004).  Age-related behavioral changes in 
humans include a progressive decline in locomotor ability, olfactory ability, memory function, 
and circadian rhythmicity (Grady, 1998; Nusbaum, 1999; Yoon et al., 2003; Onder et al., 2005).  
Age-related functional declines are particularly important because towards the end of life older 
adults are more concerned with retaining their functional capacity as opposed to prolonging their 
lifespan (Phelan et al., 2004).  In contrast to normal aging, age-related diseases are conditions 
that typically manifest at advanced ages, are associated with explicit pathology and cause 
disability and premature death.  A combination of environmental and genetic factors predisposes 
humans to age-related diseases such as diabetes, obesity, cardiovascular disease, cancer and 
neurodegeneration.  There are currently no interventions that can stop or reverse the effects of 
aging in humans.  With the improvement in health care humans are continuing to live longer and 
the number of individuals that will be affected by age-related functional declines and age-related 
diseases will continue to increase as the population ages. 
 
2. The utility of Drosophila as a model organism to study aging and age-related disease 
Model organisms that are commonly used to study aging and age-related disease include C. 
elegans, Drosophila melanogaster, and mice.  However, Drosophila has several features that set 
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this model organism apart from other model systems with regards to aging and age-related 
disease.  Most tissues in the fly are post-mitotic which is important for aging studies because 
there is evidence that functional senescence is due to the inability to maintain homeostasis in 
existing cells (Helfand and Rogina, 2003).  Most genes in Drosophila have homologs in 
mammals and the physiology between flies and mammals is generally conserved (Adams et al., 
2000).  Therefore, the molecular-genetic mechanisms associated with aging and age-related 
diseases are likely to be conserved in flies and vertebrates.  In addition, flies have a quick 
generation time, develop to adulthood quickly, have a relatively short lifespan (50-80 days), 
show functional declines quickly and have powerful genetic strategies to manipulate the genome. 
These features are all beneficial for studying aging and age-related disease (Grotewiel et al., 
2005a).  Furthermore, pathways and processes involved in many human conditions can be 
elucidated via genetic screens.  Genetic screens can be performed using behavioral assays which 
aids in the discovery of genes and pathways that accelerate or delay physiological changes that 
are associated with aging.  Genetic screens using the Drosophila eye can aid in the identification 
of interacting genes which can provide insight into the molecular and cellular mechanisms 
underlying age-related disease. Therefore, the use of genetic screens may lead to the discovery of 
therapeutics or interventions that can improve the quality of life for aging humans.  Drosophila 
are also a powerful model organism for identifying the key organ systems that fail with age and 
the pathophysiological changes that underlie many age-related functional declines and age-
related diseases. 
 
3.  The fly as a model for age-related behavioral declines 
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Commonalities in the biological and physiological systems between flies and humans allows for 
the opportunity to investigate the molecular-genetic basis for age-related behavioral declines.  
Many of the behavioral changes associated with aging in humans are also observed in 
Drosophila including a decline in locomotor ability with age, a decrease in olfactory abilities, 
and a decline in memory function (Fresquet and Medioni, 1993; Cook-Wiens and Grotewiel, 
2002).  Assays to quantitate age-related behavioral declines are readily available in flies 
(Grotewiel et al., 2005).  It is suggested that specific organ systems are involved that contribute 
to the functional declines observed in flies and not a generalized deterioration in physiological 
functioning since some behaviors do not appear to senesce in Drosophila (Cook-Wiens and 
Grotewiel, 2002).  Therefore, flies are a good model system for the elucidation of mechanisms 
that influence behavioral declines with age. 
 
4.  The fly as a model for age-related diseases 
Drosophila are very useful to delineate the mechanisms associated with age-related disease 
because of the conservation of gene function and physiology between flies and humans.  In 
addition, genetic pathways are well conserved thereby allowing for the investigation of pathways 
involved in the pathology of age-related diseases.  Flies have been successfully used to study a 
number of age-related diseases including cancer, heart failure, diabetes, and neurodegenerative 
disease.  Mechanisms underlying human carcinogenesis are being elucidated using the fly (Froldi 
et al., 2008).  This is possible because the pathways involved in tumorigenesis are conserved 
between flies and humans (Brumby and Richardson, 2005).  Drosophila are also used to 
investigate mechanisms involved in altered cardiac function that leads to heart failure in humans 
(Wolf and Rockman, 2008).  The mechanisms involved in lipotoxicity progression in humans are 
 3
conserved in Drosophila thereby making the fly useful for the study of diabetes (Kuhnlein, 
2010).  Flies have also been used successfully to model many neurodegenerative diseases in 
humans including Parkinson and Alzheimer diseases (Cauchi and van den Heuvel, 2006).  This is 
very important because not only have the molecular and cellular mechanisms of 
neurodegenerative diseases been elucidated by using this model organism but the discovery of 
drug targets and therapeutics have been revealed.  Therefore, the study of age-related diseases in 
Drosophila has the potential to identify therapeutic interventions for treatment that could 
improve the quality of life for patients afflicted with these conditions. 
 
5.   Aims of this dissertation 
This dissertation describes how I used the Drosophila model to investigate molecular-genetic 
mechanisms associated with aging and age-related disease.  The following introductory sections 
provide a review of the literature relevant to each specific aim in this dissertation.  The aim of 
Chapter 2 was to identify and characterize P element insertion mutants with a delay in age-
related locomotor impairment (ARLI) with the overall goal of identifying genes and genetic 
pathways that forestall ARLI.  A more complete understanding of the genetic basis of ARLI will 
facilitate the development of interventions that can improve the quality of life in humans with 
ARLI.  The background for this research is reviewed below under the heading Age-Related 
Locomotor Impairment and summarizes the significance of ARLI in humans, the utility of flies 
to model ARLI and the assays used to record locomotor behavior in Drosophila.  The aim of 
Chapter 3 was to use RNAi to decrease the expression level of wfs2, the fly ortholog of CISD2 to 
provide insight into the normal function of wfs2.  Furthermore, the use of Drosophila to identify 
genes and pathways that interact with wfs2 will further elucidate the possible function or 
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function(s) of wfs2 and has implications for the development of treatments or therapies for 
Wolfram Syndrome patients.  The background for this research is reviewed below under the 
heading Wolfram Syndrome:  Drosophila as a genetic model to provide insight into wfs2 
function. A brief overview of Wolfram Syndrome is provided along with a summary of what is 
currently known about the function of CISD2, the most recently discovered gene implicated in 
Wolfram Syndrome.  The aim of Chapter 4 was to identify genes that can mitigate the short 
lifespan of a model of endogenous oxidative stress via Sod2 knock-down.  The identification of 
genes and a better understanding of how they suppress the negative consequences of endogenous 
oxidative stress has implications for the treatment and management of conditions associated with 
aging and age-related disease where oxidative stress is a component.  The background for this 
research is reviewed below under the heading Oxidative Stress in Aging and Age-Related 
Disease and summarizes the role oxidative stress has on aging and age-related disease and the 
role of antioxidants in protecting against oxidative stress.     
 
Age-Related Locomotor Impairment 
 
1.  Introduction 
One of the most devastating age-related behavioral changes in humans is the progressive decline 
in the ability to walk.  In order to maintain a high quality of life, mobility is crucial because daily 
activities and therefore independence rely on locomotor skills (Pahor et al., 2006).  Walking 
speed may represent a general measure of overall health and can be an indication of risk for 
future disabilities (Onder et al., 2005). One of the key features of locomotor impairment in 
elderly individuals is reduced speed of walking (Kozakai et al., 2000; Laufer, 2005; Espeland et 
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al., 2007).  In fact, one of the most common complaints in elderly individuals is a decrease in 
mobility (Kozakai et al., 2000; Laufer, 2005; Espeland et al., 2007; Cohen-Mansfield and Frank, 
2008).  It is estimated that at least 20% of elderly uninstitutionalized people have trouble 
walking, need someone to help them walk, or require the aid of a walking device (Ostchega et 
al., 2000).  Locomotor impairment has many negative consequences within the aging population 
including an increase in falls, hospitalizations, and even future requirements for a caregiver 
(Montero-Odasso et al., 2005).  An increased fear of falling also leads to further decreases in 
mobility (Chamberlin et al., 2005). Individuals with locomotor impairment are also at greater 
risk for depression (Braam et al., 2005).  Locomotor impairment is also linked to a number of co-
morbidities including osteoporosis, arthritis, congestive heart failure, muscle pain, stroke, and 
dementia (Duxbury, 2000).  Ultimately, locomotor impairment can lead to an increase in 
mortality (Newman et al., 2006).  Therefore, locomotor impairment is a very serious 
complication associated with aging.  The molecular genetic mechanisms associated with age-
related locomotor impairment currently remain unclear in any animal.  
 
2.  Age-related locomotor impairment in flies 
The progressive locomotor decline associated with age in humans is also observed in 
Drosophila. Locomotor decline is associated with a loss of muscle mass, balance, and speed that 
is observed across humans and rodents (Giladi et al., 2005) (Altun et al., 2007).  Like humans, 
walking speed declines with age in flies (Rhodenizer et al., 2008).  Additionally, age-dependent 
decreases in muscle mass are also observed in flies (Baker, 1976).  This suggests that 
physiological changes that contribute to locomotor decline might be common across organisms 
and suggests there are evolutionarily conserved mechanisms involved that impact locomotor 
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impairment across age.  Investigation of locomotor senescence in Drosophila has the potential to 
develop interventions that may improve the quality of life for aging humans and to potentially 
delay the onset of cormobidities that are associated with locomotor impairment.   
 
3.  History of using flies to assess locomotor behavior 
Locomotor behavior can be readily assessed in Drosophila and has been studied for several 
decades. A number of assays were developed to study the effect of age on locomotor function 
including exploratory activity, negative geotaxis, and the power tower. An introduction to the 
different locomotor assays are discussed below with a more thorough review of the rapid 
iterative negative geotaxis (RING) assay that was developed in our laboratory.   
 
 
A. Exploratory Activity 
 
To assess locomotor behavior via exploratory activity, individual flies are placed in a circular 
arena and their movement within the arena is recorded (Le Bourg, 1983). As the flies age, the 
distance walked and the number of flies that do not move when placed in the arena increases (Le 
Bourg, 1983; Le Bourg and Minois, 1999).  However, it was determined that 30 day old flies 
placed in the arena may be initially less active but after time the activity levels in aged flies are 
comparable to young flies (Martin et al., 1999).  Furthermore, there are reports that declines in 
this behavior are not observed between males and females of the same genetic background, and 
exploratory activity can actually increase during the first five weeks of age in males in certain 
genetic backgrounds (Le Bourg, 1987; Fernandez et al., 1999). These complexities decrease the 
effectiveness of this assay in measuring locomotor behavior across age.   
 
B.  Single Fly Negative Geotaxis Assay 
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The single fly negative geotaxis assay has reproducibly demonstrated that climbing ability 
decreases with age (Arking and Wells, 1990; Orr and Sohal, 1994; Benguria et al., 1996; Le 
Bourg and Minois, 1999; Minois et al., 2001; Cook-Wiens and Grotewiel, 2002; Kang et al., 
2002; Goddeeris et al., 2003).  For this assay, individual flies are placed in a cylinder and are 
shaken or banged to the bottom.  The fly is observed for a period of time and the maximum 
height reached in centimeters is recorded.  Other variations of this assay are also used to measure 
climbing ability in Drosophila (Minois et al., 2001). One benefit of using the single fly assay is 
the ability to follow the locomotor behavior of a single fly across age.  In contrast, there are 
many disadvantages to using single fly assays to assess locomotor behavior in Drosophila.   
Single fly assays tend to be very labor intensive and tedious.  These limitations to the single fly 
assay are problematic when performing small experiments if the goal is to measure negative 
geotaxis behavior across age.  Additionally, this design is virtually impossible for high-
throughput studies aimed at identifying genes involved in age-related locomotor decline.  
Furthermore, single fly assays require either single flies being housed separately throughout an 
aging experiment or anesthetizing the flies to place them in vials before performing the 
experiments.  This results in a very expensive and time consuming regimen for each aging 
experiment.  Furthermore, repeatedly anesthetizing the flies could alter the behavior of the flies 
during the assay or during the aging of the flies.  All of these issues limit the utility of this assay. 
 
 
C.  Rapid Iterative Negative Geotaxis (RING) Assay 
 
To improve the assessment of locomotor behavior in flies our lab developed an assay called 
rapid iterative negative geotaxis (RING) that measures locomotor performance on groups of flies 
(Gargano et al., 2005). The RING assay consists of an apparatus that contains five tubes with 25 
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flies placed in each tube.  The apparatus is rapped against a table three times to bring all the flies 
to the bottom of the container. This stimulation initiates an escape response in the flies that 
manifests as climbing the tube walls.  A digital image is taken of the flies four seconds after 
initiating the behavior and the vertical distance climbed for each fly is determined using Scion 
image.  Five vials for each genotype are tested with multiple genotypes tested simultaneously in 
the apparatus.  Each test consists of 5 trials that include 5 digital images recording the behavior 
with testing performed weekly. The experimenter is blinded to the genotypes during testing and 
during the analysis of data, thus eliminating potential bias.  The lab determined that the data 
generated by the RING assay is highly reproducible, the number of trials has no effect on 
behavioral performance, the density of flies placed in the vial has a negligible effect on 
performance and sex has no uniform effect on locomotor behavior across age (Gargano et al., 
2005).    The lab also determined that negative geotaxis behavior is insensitive to circadian 
rhythm unlike spontaneous locomotor activity (Allada et al., 2001; Gargano et al., 2005). 
Therefore, the RING assay has many features that make it suitable for identifying flies with 
altered locomotor decline.   
 
The ability of the fly to climb is principally a legged locomotor behavior with jumping or flying 
having little if any impact on the distance climbed (Rhodenizer et al., 2008).  Further assessment 
of data generated from the RING assay revealed that there are two main changes that contribute 
to senescence of locomotor behavior in flies.  As flies age their walking speed decreases and 
their latency to start climbing the tube walls increases (Rhodenizer et al., 2008).  The lab also 
determined that the main contributor to age-related reduction in the distance climbed is a 
decrease in the climbing speed, which is a conserved feature of humans and flies during aging 
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(Rhodenizer et al., 2008).  Flies also climb at linear rates regardless of age and qualitative 
changes in the locomotor behavior with age are not obvious (Rhodenizer et al., 2008).  There are 
many benefits to the RING assay including the ability to accurately measure locomotor 
performance across age in groups of flies that is highly reproducible.  The high-throughput 
nature of the RING assay makes it very valuable for genetic screens.  One limitation of our 
RING assay is that it measures locomotor behavior across populations and not in single flies.  
Therefore, it is impossible to follow locomotor decline across age on a single fly with the RING 
assay. 
 
 
D.  Power Tower (Exercise Training Drosophila) 
 
Recently, a modification of the RING assay was developed and is called the power tower (Piazza 
et al., 2009). This assay was developed to mimic the physiological responses that are produced in 
vertebrates during endurance exercise training.  The power tower consists of a series of racks of 
tubes that are placed on a platform.  The platform rises and drops inducing the negative geotaxis 
response.  The machine was designed to repeat this process indefinitely, thereby controlling the 
duration and frequency of exercise (continuous climbing).  Interestingly, flies placed in the 
power tower demonstrated a significant improvement in mobility compared to unexercised flies.  
However, the increase in climbing ability was observed only when the flies were exercised early 
in life while exercising the flies later in life (3or 5 weeks of age) had no discernable effect 
(Piazza et al., 2009).  This assay can be useful for the identification of loci that can modulate the 
physiological response to exercise.   This is relevant for humans because a reduced incidence of 
age-related diseases and slower declines in mobility and cardiovascular function are correlated 
with exercise training (Bauman, 2004; Ascensao et al., 2007; Saraceni and Broderick, 2007).  
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With this assay it is unclear if the force of the repeated drops by the machine damages the flies 
even though the arrest rate between flies placed on the power tower and naïve flies is similar 
(Piazza et al., 2009).   
 
E. Conclusions 
The identification of genes and pathways that impact ARLI is now feasible with the creation of 
these locomotor assays.  With the development of the RING assay it is now possible to screen a 
large number of genotypes in a timely manner that is more accurate and reproducible.  The high-
throughput capacity of the RING assay allows for the ability to quickly assess the effects of 
various manipulations of genes on locomotor decline across age.  Elucidation of genes and 
mechanisms that influence locomotor decline discovered through the use of these assays are 
described below. 
 
4. Mechanisms associated with age-related locomotor impairment 
 
Locomotor behavior studies in Drosophila have generally focused on whether strains and 
mutants that are long-lived also have a delay in locomotor impairment.  If so, the data would 
suggest there are common mechanisms that influence both longevity and locomotor impairment.  
Our work along with others have revealed a number of genes that influence locomotor 
impairment and are associated with a number of pathways or processes including alterations in 
insulin signaling, environmental sensing, protein damage repair, muscle structure, antioxidant 
function, and drug treatment.  These mechanisms are discussed in more detail below. 
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One pathway known to influence lifespan is the insulin signaling pathway (Tatar et al., 2003b).  
There is evidence that loss of function mutations in the insulin signaling pathway influences 
ARLI in a number of species.  In C. elegans daf-2 (insulin receptor) mutants have delayed ARLI 
(Huang et al., 2004). In Drosophila, chico mutants tested using our RING assay have delayed 
ARLI (Gargano et al., 2005).  Although humans with polymorphisms within the insulin signaling 
pathway components have a longer lifespan (Suh et al., 2008; Willcox et al., 2008) it is unclear 
whether individuals with these polymorphisms or others retain their locomotor ability longer 
than the general population.   
 
There is evidence that alteration in environmental sensing can positively impact ARLI.  In 
Drosophila or83b (an odorant receptor) mutants have delayed ARLI compared to controls 
(Rhodenizer et al., 2008).  Or83b oligomerizes with other receptors to form functional receptors 
for detecting odorants (Larsson et al., 2004). Our results using the RING assay suggests that 
olfactory cues can influence this aspect of aging.   
 
There is also evidence that genes involved in muscle structure may alter ARLI.  The X-linked 
gene myospheroid in Drosophila encodes βPS (β position-specific), the major β-integrin in flies 
(MacKrell et al., 1988).  During development integrins function to attach the ends of muscles to 
the tendon matrix and play a role in the assembly of muscle structure (Bokel and Brown, 2002).   
The lab found that three independent loss of function alleles in mysopheroid resulted in delayed 
ARLI (Goddeeris et al., 2003).   This suggests that alterations in muscle structure during 
development may impact ARLI. 
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Cellular repair processes decline with age and are associated with senescence (Knight, 2000).  
Reduced functioning of antioxidant enzymes that reduce oxidative stress on the organism can 
have a negative impact on functional status.  For example, ubiquitous knock-down of the 
antioxidant enzymes SOD1 (cytoplasmic Sod) or SOD2 (mitochondrial Sod) via RNAi 
accelerates ARLI (Martin et al., 2009a; Martin et al., 2009b).  A complete loss of SOD2 activity 
in mice also causes disturbed locomotor function (Lebovitz et al., 1996).  In contrast, 
overexpression of enzymes that function to repair damaged proteins can positively impact 
locomotor behavior.   For example, ubiquitous overexpression of protein carboxyl 
methyltransferase (PCMT), a protein damage repair enzyme enhanced locomotor activity in 
Drosophila (Chavous et al., 2001).  Another enzyme that repairs oxidative damage to proteins is 
peptide methionine sulfoxide reductase A (MSRA).  Overexpression of MSRA in the nervous 
system in flies delayed the onset of reduced physical activity levels associated with age 
compared to controls (Ruan et al., 2002).   This fly was also found to be resistant to oxidative 
stress raising the question of whether there may be a connection between enhanced oxidative 
stress resistance and delayed ARLI (Ruan et al., 2002).   However, there is evidence that 
oxidative stress resistance can be uncoupled from ARLI.  For example, resistance to oxidative 
stress with no delay in age-related locomotor impairment was observed in Methuselah mutants 
(Cook-Wiens and Grotewiel, 2002).  Furthermore, a delay in age-related locomotor impairment 
without resistance to oxidative stress was observed in loss of function mutants in the β-integrin 
myospheroid (Goddeeris et al., 2003).  These studies suggest that enhanced or proper functioning 
of enzymes that decrease oxidative stress and repair damaged proteins are important in 
sustaining locomotor ability across age.   
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Currently, there are no drug treatments to delay the onset of ARLI.  However, there is evidence 
that inhibiting histone deacetylase by using the drug 4-phenylbutyrate (PBA) can have beneficial 
effects on age-related locomotor impairment.  Flies fed PBA maintained their climbing ability 
with age compared to controls (Kang et al., 2002). It has been suggested that PBA treatment can 
activate repair mechanisms and possibly inhibit the accumulation of damage with age thereby 
having a beneficial effect on locomotor ability (Kang et al., 2002). 
 
5.  Connections between age-related locomotor impairment and longevity 
 
There are a number of mechanisms that appear to influence age-related locomotor decline in 
Drosophila.  Many of these mechanisms were first identified as extending lifespan.  Studying 
ARLI has provided insight into whether the ability to maintain locomotor function across age is 
mechanistically tied to lifespan.  There is evidence that lifespan and ARLI can be experimentally 
uncoupled.  For example, the long lived Drosophila mutant methuselah extends lifespan (Lin et 
al., 1998) but does not alter ARLI (Cook-Wiens and Grotewiel, 2002). We observed the same 
effect when placing flies under dietary restriction (Bhandari et al., 2007).  In contrast, mutations 
in myospheroid have an increase in lifespan and delayed ARLI (Goddeeris et al., 2003). 
Additionally, pan-neuronal overexpression of MSRA increases lifespan and enhances locomotor 
behavior in aged flies (Ruan et al., 2002).  Long-lived chico mutants  (Clancy et al., 2001; Tu et 
al., 2002) also have delayed ARLI (Gargano et al., 2005).  These studies suggest ARLI may be 
driven by mechanisms that are independent or distinct from those that impact lifespan.  
Therefore, an extension of lifespan may not positively impact all aspects of aging including 
ARLI.   Further study to elucidate which mechanisms differ between lifespan and delayed ARLI 
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will provide insight into genetic or cellular pathways that positively influence each aspect of 
aging independently. 
 
6.  Summary 
ARLI is very detrimental to the population and causes an increase in morbidity and mortality.  
Drosophila have proven to be a valuable model organism to study locomotor impairment across 
age.  The development of the RING assay to conduct large scale genetic screens to assess 
locomotor behavior across age has the potential to identify molecular genetic mechanisms and 
processes associated with this aspect of aging.  The identification of genes that influence ARLI 
will provide a more complete understanding of mechanisms and pathways that impact locomotor 
behavior across age and has implications for future interventions and therapies to improve the 
quality of life in elderly humans.   
 
Wolfram Syndrome:  Drosophila as a genetic model to provide insight into wfs2 function  
 
1.  Introduction 
Neurodegenerative diseases including Parkinson disease, Alzheimer disease and polyglutamine 
diseases have all been successfully modeled in Drosophila (Cauchi and van den Heuvel, 2006).  
Many neurodegenerative disease genes are structurally and functionally conserved in flies, 
raising the possibility that discoveries identified in flies could be applicable to humans.  
Drosophila are very useful in investigating the molecular-genetic mechanisms underlying these 
neurodegenerative diseases because phenotypes can be readily observed and assessed (Reiter et 
al., 2001).  In addition, modifier screens are commonly used to identify interacting genes and 
pathways that may be involved in disease pathology.  The eye is commonly used for modifier 
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screens in Drosophila because variations in eye morphology are easily observed under the light 
microscope.  In addition, severe degeneration of the eye does not negatively impact survival.  
Therefore, Drosophila are very beneficial in delineating the molecular and cellular processes 
underlying neurodegenerative disease.  The following is a review of the literature on the rare 
neurodegenerative disease called Wolfram Syndrome.     
 
2.  Wolfram Syndrome 
Wolfram Syndrome (WFS) is a rare autosomal recessive progressive neurodegenerative disease 
that affects roughly 1 in 770,000 people in the UK (Barrett et al., 1995).  The prevalence of this 
disorder in the Lebanese population is higher with 1 in 68,000 individuals affected due to the 
high rates of consanguinity (Medlej et al., 2004).   The four main features of this disorder include 
diabetes mellitus, diabetes insipidus, optic atrophy and deafness (DIDMOAD) (Wolfram, 1938).  
However, the only two features required for the Wolfram Syndrome diagnosis are diabetes 
mellitus and optic atrophy (Barrett et al., 1995).  Diabetes mellitus is a progressive disorder 
caused by deterioration in pancreatic β-cell function and insulin resistance (Bollyky et al., 2008).  
Diabetes mellitus is the first manifestation of this disorder and is due to the degeneration of the 
pancreatic β-cells along with a decrease in the level of circulating insulin (Barrett et al., 1995).  
Initial symptoms of optic atrophy are typically mild and include loss of both color and peripheral 
vision (Barrett and Bundey, 1997).  Optic atrophy is progressive and patients usually go blind 
within eight years after the initial diagnosis (Barrett and Bundey, 1997).    Diabetes insipidus is 
only seen in about 73% of patients but usually manifests in the second decade of life (Barrett et 
al., 1995).  Diabetes insipidus is caused by inadequate or impaired release of the antidiuretic 
hormone (ADH) from the hypothalamus (Makaryus and McFarlane, 2006) .  High frequency 
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sensorineural hearing loss manifests in the second or third decade of life and is seen in about 
62% of patients (Barrett et al., 1995).  Numerous other features are also associated with this 
disorder.  Psychiatric illness is sometimes observed and includes suicidal behavior (Strom et al., 
1998).  Renal-tract abnormalities (Barrett et al., 1995) can also be observed.  Neurological 
manifestations include ataxia of the trunk, loss of gag reflex, loss of olfaction, seizures, and 
involuntary eye movement (Rando et al., 1992; Barrett et al., 1995). Atrophy of visual pathways, 
the brainstem, or the cerebellum is also observed (Pakdemirli et al., 2005; Ito et al., 2007).  
Gastrointestinal manifestations are less common but do occur in some patients and include bowel 
dysmotility and muscle weakness in the stomach that results in the difficulty of passing food 
through the stomach (Barrett et al., 1995; Medlej et al., 2004).  All features that are associated 
with this disorder have differing ages of onset (Table 1).  Patients usually die within the 3rd 
decade of life due to respiratory failure associated with brainstem atrophy (Scolding et al., 1996).  
 
3.  Wolfram Syndrome is caused by loss of function mutations in WFS1 and CISD2 
Wolfram Syndrome is a genetically heterogeneous disorder with causative mutations identified 
in two genes.  The first gene identified was WFS1 and it is reported that 90% of Wolfram 
Syndrome patients have mutations in this gene (Khanim et al., 2001). This gene is widely 
expressed with abundant expression in the brain, pancreas, heart, and muscle.   The WFS1 
protein product wolframin is well studied. Wolframin is a transmembrane protein that is 
localized to the ER and plays a role in ER calcium homeostasis.  For example, knock-down of  
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Table 1:  Clinical features of Wolfram Syndrome, prevalence and median age of onset.  
Data collected from a number of sources and reviewed in (Kumar, 2009). 
 
Clinical Feature Prevalence Average onset (age)
Diabetes mellitus 100% 6 years 
Optic Atrophy 100% 11 years 
Diabetes Insipidus 73% 14 years 
Deafness 62% 16 years 
Urological abnormalities 58% 3rd decade 
Neurological complications 62% 4th decade 
Psychiatric or behavioral disorder 60% Variable 
Gastrointestinal tract problems 20-30% Variable 
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WFS1 in HEK293 cells results in lower levels of ER calcium supporting a role of Wolframin in 
ER calcium uptake (Takei et al., 2006).  Wolframin is also predicted to play a role in the ER 
stress response.  The unfolded protein response (UPR) is activated by ER stress and serves to 
limit the amount of accumulated misfolded proteins in the ER (Zhang and Kaufman, 2006).  The 
UPR consists of three branches IRE1, PERK, and ATF6. The UPR is controlled by these three 
genes which become activated by the accumulation of unfolded or misfolded proteins in the ER. 
(Zhang and Kaufman, 2006).  WFS1 was discovered to be a novel downstream component of 
IRE1 and PERK signaling in the UPR (Osman et al., 2003).  Additionally, WFS1 deficiency in 
beta-cells causes chronic ER stress via upregulation of ER stress markers (Fonseca et al., 2005).  
An enhanced ER stress response was also reported in pancreatic islets cells isolated from wfs1 
deficient mice (Yamada et al., 2006).  Therefore, some insight into the function of WFS1 has 
been elucidated by a number of studies.   
 
The second and more recently discovered gene associated with Wolfram Syndrome is CDGSH 
iron sulfur domain 2 (CISD2).  Mutations in this gene were identified in three unrelated 
consanguineous Jordanian families with Wolfram Syndrome (Amr et al., 2007).  A splice site 
mutation was identified in these families that cause a frameshift in the transcript that generates a 
stop codon that is proposed to eliminate the full-length transcript (Amr et al., 2007).  Additional 
phenotypes are observed in these individuals that are unique to mutations in this gene including 
bleeding tendency and defective platelet aggregation with collagen (al-Sheyyab et al., 2001).  
Peptic ulcer disease with gastrointestinal tract bleeding is also a common finding in patients with 
CISD2 mutations (Ajlouni et al., 2002).  CISD2 is expressed in a wide variety of tissues 
including the pancreas and brain (Amr et al., 2007).  CISD2 transcripts were found in platelets, 
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which explains the bleeding tendency (Peri et al., 2003).  CISD2 is not expressed in fetal liver, 
skeletal muscle, or cartilage (Amr et al., 2007).   The CISD2 gene product ERIS (endoplasmic 
reticulum intermembrane small protein) also localizes to the ER and contains a single 
transmembrane domain and a single iron sulfur domain.  Unlike WFS1, knock-down of CISD2 in 
patient insulinoma cells and lymphoblastoid cells did not have an upregulation of UPR markers 
compared to controls suggesting CISD2 may not play a role in the UPR (Amr and Shiang, 
personal communication).  Additional analysis using co-immunoprecipitation studies suggested 
that Wolframin does not interact with ERIS (Amr et al., 2007).  Interestingly, CISD2 was 
recently discovered to function within the Beclin-1 mediated autophagy pathway suggesting a 
role of CISD2 in the regulation of autophagy (Chang et al., 2009).   Despite several advances in 
understanding ERIS (the CISD2 gene product), its function or function(s) have not been fully 
resolved.   
 
4.  Animal Model to investigate the physiological function of CISD2 
Recently, a CISD2 knock-out mouse was created that recapitulates many of the features of 
Wolfram Syndrome in humans including reduced lifespan, progressive neurodegeneration, and 
impaired glucose tolerance (Chen et al., 2009).  This group localized ERIS primarily to the outer 
mitochondrial membrane which differs from previous reports of CISD2 being primarily localized 
to the ER (Amr et al., 2007; Wiley et al., 2007).   In addition, these mice have mitochondrial 
degeneration that is accompanied by cell death caused by autophagy and precedes the muscle 
and nerve degeneration observed in these mice (Chen et al., 2009).  Given the phenotypes of 
these knock-out mice the authors suggest Wolfram Syndrome is a mitochondrial mediated 
disorder.  The tissues affected in this disorder have a high energy demand supporting this idea.  
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However, controversy exists in previous clinical studies as to whether there is a mitochondrial 
component to Wolfram Syndrome.  One study identified abnormal mitochondria in a muscle 
biopsy of a patient, suggesting that a mitochondrial defect could be causative for Wolfram 
Syndrome (Bundey et al., 1992).  However, other clinical studies found no evidence of 
mitochondrial deficiency in patients (Hofmann et al., 1997a; Barrett et al., 2000).  Therefore, this 
mouse model supports a mitochondrial component to this disease but further study is needed to 
solidify whether Wolfram Syndrome is in fact a mitochondrial mediated disorder.   
 
5.  Summary 
The biochemical properties of the CISD2 gene product are starting to be elucidated.  Although 
the mouse knock-out model provides some insight into the physiological role of CISD2 the 
function or function(s) of this gene have not been fully resolved.  Furthermore, the genes and 
pathways associated with CISD2 have yet to be identified.  Insight into the molecular 
mechanisms that contribute to Wolfram Syndrome can be gained through the study of the normal 
function of CISD2 in Drosophila. This has implications for the diagnosis and treatment of 
patients with this disorder along with other individuals afflicted with diabetes and 
neurodegeneration.   
 
Oxidative Stress in Aging and Age-Related Disease 
 
1.  Introduction 
Oxidative stress has long been implicated in the aging process and plays a contributing factor in 
age-related disease.  Oxidative stress is caused by the imbalance between the production of 
prooxidants and antioxidant defense mechanisms.  Mitochondria are the major producers of 
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superoxide, a reactive oxygen species (ROS) that is formed as a byproduct of cellular respiration 
(Fridovich, 2004).  The generation of ROS from mitochondria is primarily determined by 
metabolic conditions, can be produced at high rates and is therefore mostly associated with 
damaging processes.  Mitochondria consume more than 90% of cell O2 and the electron transport 
chain continuously reduces one O2 molecule into two H2O molecules with at least 0.1% or more 
of O2 being reduced to superoxide (O2-) (Chance et al., 1979; Fridovich, 2004).  Redox reactions 
involving O2- generates other reactive oxygen species including the hydroxyl radical (OH-) that 
is highly reactive and results in oxidative damage to macromolecules (Chance et al., 1979).   
 
There are number of antioxidant enzymes that limit the damage from ROS and function to 
protect cells from oxidative stress.  These enzymes include superoxide dismutases, catalase, and 
glutathione peroxidases which all convert ROS to less reactive products.  Superoxide dismutases 
are responsible for capturing the superoxide produced and converting it to H2O2 and O2 
(Halliwell and Gutteridge, 1999).  The two main superoxide dismutases are Sod1 that is located 
in the cytosol and Sod2 that is located in the mitochondrial matrix (Landis and Tower, 2005).  
Additional antioxidant systems include catalase, glutathione peroxidase and thioredoxin 
peroxidase that are responsible for converting H2O2 to H2O and O2 (Matthews et al. 2000).  All 
of these enzymes function to protect cells from oxidative stress.  These antioxidant enzymes are 
conserved between flies and humans thereby making Drosophila a good model system to study 
antioxidant function (Missirlis et al., 2001).  Enhanced functioning of antioxidant enzymes has 
beneficial effects on lifespan in Drosophila.  Although overexpression of Sod2 during 
development and adulthood does not extend lifespan in Drosophila there is an extension of mean 
lifespan by 33% in Drosophila when this enzyme is conditionally overexpressed only during 
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adulthood (Paul et al. 2007 and Sun et al. 2002).  Overexpression of Sod1 alone or Sod1 and 
catalase also extends lifespan in Drosophila (Sun and Tower 1999, Orr and Sohal 1994).  
Therefore, antioxidant enzyme function is very important for protecting against oxidative stress 
and in preserving lifespan. 
 
2.  Oxidative stress in aging 
Accelerated aging and shortened lifespan are associated with the cumulative oxidative damage to 
DNA, lipids and proteins by reactive oxygen species (ROS) (Beckman and Ames, 1998).  This 
damage causes the deterioration of cells, tissues and organ systems that culminates in functional 
senescence and a shortened lifespan (Harman, 1956).  Oxidative damage is associated with age-
related declines in behavior and function (Joseph et al., 1999; Liu et al., 2003).  ROS content 
rises with age in a number of organisms and the rate at which aging occurs is correlated with the 
rate of ROS production (Sohal et al., 1990b; Sohal and Sohal, 1991; Sohal et al., 1994; Sohal et 
al., 1995).  The number of oxidized proteins in humans and flies increases with age along with 
the accumulation of oxidative damage to macromolecules (Starke-Reed and Oliver, 1989; Orr 
and Sohal, 1994; Sohal et al., 2002).  With age, mitochondria have increased damage to their 
genome and the inner membrane and have a decline in respiratory activity.  Consequently, these 
changes further lead to an increase in ROS generation by the mitochondria and causes further 
oxidative damage to the organism (Hillered and Ernster, 1983; Sohal et al., 1994).  Oxidative 
damage is even detectable in young animals suggesting that this damage accumulates for years 
until functional status is impaired (Agarwal and Sohal, 1994).  In addition, oxidative damage to 
mitochondrial DNA in brain and heart tissue and an increase in oxidative damage to DNA, 
lipids, and proteins in skeletal muscle is observed in older humans (Mecocci et al., 1999; Barja 
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and Herrero, 2000).  In fact, it is estimated that in some tissues with age there is oxidative 
damage to at least 30% of total cellular protein (Starke-Reed and Oliver, 1989).  Additionally, 
survival in Drosophila declines with age when exposed to paraquat, a free radical inducer, 
demonstrating that the ability to counteract exogenous oxidative stress also declines with age 
(Bonilla et al., 2002). This evidence highlights the significance of oxidative damage on 
decreased functioning and increased mortality with age. 
 
A number of mechanisms are suggested to contribute to the accumulation of oxidative damage 
with age.  During aging, the function of some antioxidants decreases while others remain 
unchanged or actually increase suggesting that aging is not due to a global deterioration in 
antioxidant function (Sohal et al., 1990a; Sohal et al., 1990b; Sohal and Weindruch, 1996).  
However, an increase in mitochondrial ROS production is associated with increased oxidative 
damage (Sohal and Weindruch, 1996).  Activity of enzymes involved in repairing oxidative 
damage to DNA (Petropoulos et al., 2001) and proteins (Chen et al., 2002) decreases with age.  
For example, activity of MSRA and several mitochondrial DNA glycosylases decline with age in 
a number of tissues (Petropoulos et al., 2001; Chen et al., 2002; Imam et al., 2006).  This 
suggests that the inability to repair damaged proteins and DNA contributes to the accumulation 
with age. The organelle that is responsible for removing proteins with oxidative damage is the 
proteasome and the activity of this organelle decreases with age in a number of tissues (Shibatani 
et al., 1996; Shang et al., 1997; Bulteau et al., 2000; Keller et al., 2000; Petropoulos et al., 2000; 
Louie et al., 2002; Carrard et al., 2003; Husom et al., 2004; Viteri et al., 2004).  Consequently, 
reduced function of macromolecules that repair oxidatively damaged proteins and DNA and 
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degradative systems that remove oxidatively damaged proteins contribute to the accumulation of 
oxidative damage associated with aging. 
 
3.  Oxidative Stress and Age-Related Disease 
Oxidative stress is also thought to contribute to a number of human age-related diseases 
including sarcopenia, cancer, diabetes, coronary artery disease and neurodegenerative diseases 
(McFarland et al., 2002, 2007; Pieczenik and Neustadt, 2007).   In rats, aged muscle undergoing 
sarcopenia had increased rates of electron transport chain abnormalities suggesting that 
mitochondrial abnormalities are associated with muscle fiber loss (Bua et al., 2002).  There is 
also an association with increased oxidative damage and cancer.  Mice that have a 50% decrease 
in function of Sod2 show an increase in oxidative damage and an increase in the incidence of 
cancer (Van Remmen et al., 2003).  Diabetic patients are reported to have an increase in 
oxidative damage compared to individuals without this condition (Akkus et al., 1996; Atalay et 
al., 1997).  Defective oxidative phosphorylation results in an increase in oxidative damage and 
contributes to artherosclerosis during aging (Bogliolo et al., 1999).  Defective oxidative 
phosphorylation is also associated with hypertrophic cardiomyopathy (Zeviani et al., 1995).    
 
Oxidative stress is also implicated in a number of human neurodegenerative diseases.  Tissues 
involved in neurodegenerative diseases are very susceptible to oxidative stress due to the high 
energy demand that is required for proper functioning.  Huntington disease (HD) brain 
mitochondria from patients show an increase in oxidative damage (Polidori et al., 1999). There is 
also an increase in production of ROS in transgenic mouse models of HD (Perez-Severiano et al., 
2004).  An increase in oxidative damage but a decrease in DNA repair mechanisms that remove 
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oxidized bases in DNA is observed in Alzheimer disease patients (Lovell et al., 1999).  
Mitochondrial and oxidative stress are both implicated in the pathogenesis of Parkinson’s disease 
(Greenamyre and Hastings, 2004).  Oxidative stress increases ischemic injury after a stroke and 
is believe to be due to reduced oxygen levels during the stroke that results in an increase in 
superoxide production (Gilgun-Sherki et al., 2002).   Friedrich’s Ataxia is also associated with 
oxidative stress where loss of the protein Frataxin causes iron overload that inactivates 
mitochondrial enzymes and oxidizes cellular components (Schon and Manfredi, 2003). 
 
A number of animal models for these diseases exhibit sensitivity to exogenous oxidative stress.  
A Drosophila model of Alzheimer disease is sensitive to H2O2 compared to controls (Rival et al., 
2009).  Familial forms of Parkinson disease are associated with the genes Pink1 and Parkin.  
Mutations in these genes in Drosophila predisposes to sensitivity to the exogenous oxidative 
stressor paraquat (Pesah et al., 2004; Clark et al., 2006).   A Drosophila model for Friedrich 
ataxia demonstrated that reduced Frataxin levels via RNAi caused sensitivity to oxidative stress 
(Llorens et al., 2007).  Flies expressing the amyloid β1-42 peptide have an increased sensitivity to 
H2O2 compared to control flies (Rival et al., 2009).  This evidence demonstrates a reduced ability 
to handle exogenous oxidative stress in these diseases.  Therefore, oxidative stress plays a 
significant role in the progression of many age-related diseases. 
 
4.  Consequences of reduced antioxidant function 
A reduction in the function of antioxidant enzymes results in detrimental effects to the organism 
and can lead to reduced lifespan.  Both Sod1 and Sod2 null flies have reduced lifespan (Phillips 
et al., 1989; Duttaroy et al., 2003).   Sod1 knock-out mice have a 30% reduction in mean lifespan 
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(Elchuri et al. 2005) and motor impairments (Shefner et al., 1999).  Decreased expression of 
Sod2 in Drosophila via Sod2 RNAi increases the amount of endogenous oxidative stress in 
adults (Kirby et al., 2002).  Mice null for Sod2 have motor impairments, neurodegeneration, 
dilated cardiomyopathy, motor disturbances and perinatal death (Li et al., 1995; Lebovitz et al., 
1996).  Reduction of Sod2 and thioredoxin reductase (TrxR) in Drosophila decreases lifespan 
(Kirby et al., 2002; Missirlis et al., 2002).   A shortened lifespan is observed in Drosophila with 
decreased function of catalase and in mice with knock-out of catalase (Mackay and Bewley, 
1989; Ho et al., 2004).  Disruption of the peroxidase PHGpx (phospholipid hydroperoxide 
glutathione peroxidase) that is responsible for reducing peroxidized lipids results in embryonic 
lethality in mice (Imai et al., 2003).   A number of age-related diseases in humans also have 
reduced antioxidant function.  Diabetic patients have decreased Sod and catalase levels due to 
hyperglycemia (Akkus et al., 1996; Atalay et al., 1997).  Many tumors have a reported reduction 
in Sod2 expression levels and transformation of tumors with Sod2 cDNA reverses the malignant 
phenotype (Xu et al., 1999).  Coronary heart disease is also associated with reduced intracellular 
Sod levels (Wang et al., 1998).  This highlights the detrimental effects due to elevated levels of 
endogenous oxidative stress due to decreased function of antioxidant enzymes.  Oxidative stress 
is a component of many diseases and is not classified as a disease itself.  No clinical therapies 
currently exist that use SOD or any other antioxidant enzymes to aid in the clearance of 
superoxide production.  Therefore, there is a need to identify genes than can protect against 
endogenous oxidative stress. 
 
5.  Summary 
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These studies highlight the importance of these antioxidant enzymes for the continuous 
surveillance in the cell to decrease oxidative stress on the organism.  The consequence of 
decreased functioning of these enzymes reduces survival and functioning of the organism.  Loss 
of function of these enzymes not only impacts aging but also the underlying pathology of a 
number of age-related and neurodegenerative diseases.  Although lifespan has been well studied 
with respect to alterations in antioxidant function, it remains to be determined whether 
manipulation of certain genes can counteract endogenous oxidative stress on the organism.  
Many of these antioxidant enzymes are conserved in Drosophila (Jacobs et al., 2004) making 
this model organism very useful in the study of mechanisms that can mediate endogenous 
oxidative stress.  Studies that identify, investigate and provide a better understanding of the 
genetic mechanisms that suppress the negative consequences of endogenous oxidative stress 
have implications in the treatment and management of diseases associated with the accumulation 
of oxidative damage.  The modulation of oxidative stress has the potential to delay or decrease 
the severity for a number of age-related diseases and neurodegenerative conditions. 
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Chapter 1 
 
Materials and Methods 
 
 
1.1 Fly husbandry, fly strains, and genetics 
All flies for all studies were reared at 25˚C and 60% relative humidity under a 12-hour light/dark 
cycle on standard Drosophila medium (10% sucrose, 2% yeast, 3.3% cornmeal, 1% agar, 0.2% 
Tegosept) supplemented with active yeast.  For all aging studies, adult flies (1-3 days old) were 
briefly anesthetized with carbon dioxide (CO2) and then placed into fresh food vials at 25 flies 
per vial.  Adult flies were transferred to fresh food vials twice weekly for all studies.  Age-
Related Locomotor Impairment Project:  EP lines were obtained from the Drosophila Stock 
Center (Bloomington, IN, USA).  pGawB lines were kindly provided by Laurent Seroude 
(Queens University, Kingston, ON, Canada).  Our standard laboratory stock, w, contains the 
w1118 allele in the Canton-S genetic background.  All EP and pGawB element chromosomes 
identified in the primary and secondary screens were backcrossed for seven generations to w[cs] 
prior to testing in the confirmation phase of the screen.  Revertant chromosomes generated by 
precise excision of EP837 from the PDK1 locus were generated using the ∆2-3(99B) transposase 
source as described (Stoltzfus et al., 2003).    
Wolfram Syndrome Project:  da-Gal4, mef2-Gal4, 188Y-Gal4, appl-Gal4, and all PPT1 
modifiers were obtained from the Bloomington Drosophila Stock Center (Bloomington, IN).  
UAS-RNAi transgenic lines for wfs2 (33925 and 33926, a.k.a. WFS2.1 and WFS2.2, 
respectively), CLN3 (5322) and CLN7 (5089 and 5090) were purchased from the Vienna 
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Drosophila Research Center (Vienna, Austria).  The GMR-WFS2.1 and the GMR-WFS2.2 
double transgenic flies were created by recombining the GMR-Gal4 element and the wfs2 RNAi 
transgenes onto the same chromosome and were confirmed by PCR with primers that detected 
both transgenes independently (Table 2).  PPT1 loss of function mutants (PPT1-A179T and 
PPT1-S77F) were provided by Robert Glaser (Wadsworth Center, Albany NY).  CLN3 
overexpression strains (UAS-CLN3 #4, GMR-CLN3 #8) were provided by Richard Tuxworth 
(Kings College London, London UK).  Sod2 Candidate Suppressors Project:  Sod2 was knocked-
down by using the Gal4/UAS system (Brand and Perrimon, 1993) to express Sod2 inverted 
repeat (Sod2-IR) transgenes previously described (Kirby et al., 2002). The UAS-Sod2-IR24, 
UAS-Sod2-IR15 and daughterless-Gal4 (da-Gal4) lines were provided by John Phillips 
(University of Guelph).  UAS-DJ-1β-IR1 (transformant 17214) and UAS-DJ-1β-IR2 
(transformant 17215) (Vienna Drosophila RNAi Center, Vienna, Austria).  Flies with a second 
chromosome harboring the Actin-Gal4 and UAS-Sod2-IR15 transgenes and flies with a third 
chromosome harboring the da-Gal4 and UAS-Sod2-IR15 transgenes were generated through 
recombination and confirmed by PCR with primers that detected both transgenes independently 
(Table 2).  The Actin-Gal4::Sod2-IR15 chromosome and the da-Gal4::Sod2-IR15 chromosome 
are homozygous lethal and are therefore maintained in a heterozygous state over a balancer 
chromosome (CyO or Sb).  
 
1.2 Negative Geotaxis, Lifespan, and Bang Sensitivity 
 Negative geotaxis (startle-induced climbing) was analyzed in Rapid Iterative Negative Geotaxis 
(RING) assays as described previously (Gargano et al., 2005).  Briefly, negative geotaxis was 
assessed in 125 animals per genotype with 25 flies per vial at the indicated ages.  Statistical  
 30
Table 2:  PCR primers to confirm recombinant flies. Primers used to confirm GMR-WFS2.1 
and GMR-WFS2.2 and Actin-Gal4::Sod2-IR15, da-Gal4::Sod2-IR15 recombinants. 
 
Transgene or 
Gene 
Primer 
Actin-Gal4 5’-GGGTTTGGTGGGGTATCTTCATC-3’ 
 5’-CATTAGTGCCACTGACCCCGTC-3’ 
Da-Gal4 5’-GGGTTTGGTGGGGTATCTTCATC-3’ 
 5’-CATTAGTGCCACTGACCCCGTC-3’ 
Gmr-Gal4 5’-GGGTTTGGTGGGGTATCTTCATC-3’ 
 5’-CATTAGTGCCACTGACCCCGTC-3’ 
UAS-Sod2-IR 5’-GAACACGTCGCTAAGCGAAAGC-3’ 
 5’-GCGAAATTTTACGGGCCACGAAC-3’ 
UAS-WFS2.1-IR 5’-CGCGAATTCTCAAGGATTGGTTGGCCCTGATCC-3’ 
 5’-GAGGCGCTTCGTCTACGGAGCGAC-3’ 
UAS-WFS2.2-IR 5’-CGCGAATTCTCAAGGATTGGTTGGCCCTGATCC-3’ 
 5’-GAGGCGCTTCGTCTACGGAGCGAC-3’ 
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treatment of data (one-way analysis of variance) was performed using JMP 5.01.  Lifespan was 
assessed as previously described (Martin et al., 2009b).  Log-rank tests on lifespan data were  
performed with JMP 5.01.  Bang sensitivity (seizure susceptibility) was assessed by determining 
the climbing latency (i.e. time to recovery) in groups of 25 flies after being vortexed in a vial for 
15 seconds at the highest setting using a Diagger Vortex Genie 2 (Fergestad et al., 2006). 
 
1.3 PCR and inverse PCR   
Age-Related Locomotor Impairment Project:  Confirmation of previously mapped P-element 
insertions was performed using primers that anneal to genomic DNA flanking the insertion sites 
and to the P-elements (Table 3) using standard protocols.  The locations of previously unmapped 
PGawB elements were identified through inverse PCR (Dalby et al., 1995).  Genomic DNA was 
isolated from a sample of 50 flies from each pGawB line using a DNeasy Blood and Tissue Kit 
(Qiagen).  Genomic DNA was digested with DpnII or MspI and then self-ligated with T4 DNA 
ligase (Invitrogen).  Ligation products were used as templates for inverse PCR using primers (5’-
CCCCACGGACATGCTAAGG-3’, 5’-
CTCATAATATTAATTAGACGAAATTATTTTTAAAG-3’) that anneal to the 3’ end of 
PGawB.  Amplification products from inverse PCR reactions (i.e. DNA flanking the pGawB 
insertions) were sequenced using a primer (5’- CGACACTCAGAATACTATTCCTTTCAC-3’) 
that anneals near the 3’ end of pGawB.    
 
1.4 Quantitative real-time PCR 
mRNA expression was assessed via quantitative real-time PCR (qRT-PCR) studies as previously 
described (Jones et al., 2009).  Briefly, groups of 25 male flies frozen at -80oC.  Total RNA was 
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Table 3.  PCR primers for confirmation of P-element insertion sites 
 
Gene or 
Transposon 
Allele 5’ Primer 3’ Primer 
PDK1    EP837 5’-TTGGCCTTATGTAGTTGTGTGG-3’ 5’-CAATCGGTTAAATACTTTGAACAC-3’
   
   
  
    
    
   
   
   
  
   
 
    
EP3553 5’-GAGCGTGCGCTCTCTTTGGC-3’ 5’-CGAGACGCTGTATGTGTCTG-3’
BG02759 5’-CAGTGCAACAATTACGCTCTC-3’ 5’-CGAGACGCTGTATGTGTCTG-3’
Pfrx EP1150 5’- CGGCGACAA GTGGACCCAT AAATAGTCC-3’ 5’-GAGGTAGCTACAATCCGCACAAAAAC-3’
Doc3 DJ708 5’-CGTGCCTCCGAAATTACAGC-3’ 5’- CATAGGGGATCTGTGGTAGAC-3’
m6/HLHm7 DJ913
DJ996 
DJ1026 
5’-GAGCTGGCCATGTGCAGCTC-3’ 5’-GTTAGCTGCGACGGTGAGTGG-3’
CG14045 EP1174 5’-CTACGTCGCCTGGCGAACTG-3’ 5’-GGTGGCTGAAACACAGATCAG-3’ 
Dp110 c00368 5’-GAGATCGTGCTGTTAAGCGTCTG-3’ 5’-GAATGCTGTTAATCAGTGTCGC-3’ 
e03435 5’-CAGCACGCCAATCTCTCTGC-3’ 5’-GAGCTGCGCCACAATGCAAG-3’
Akt c02098 5’-CGATACAATCAGAATCACAGTCC-3’ 5’-CTGCTTGGCCAGGATTGCTGC-3’ 
EY10012 5’-CAGTTATCGAGCCAGTTATCG-3’ 5’-GCTGTACAAATGTCGCTATCTAT-3’
EP and 
pGawB 
5’-CGACGGGACCACCTTATGTTATTTCATCATG-3’ 5’-CGACGGGACCACCTTATGTTATTTCATCATG-3’ 
pBac 5’-CAGTGACACTTACCGCATTGACAAGCAC-3’ 5’-CCTCGATATACAGACCGATAAAACACAT-3’
 
 
 
isolated using TRIZOL (Invitrogen) and reverse transcribed using oligo(dT) primers and 
Superscript II reverse transcriptase (Invitrogen).  qRT-PCR was performed using an Applied 
Biosystems Fast 7500 system.  All assays were performed in triplicate with three independent 
RNA and cDNA isolations and normalized to Actin5c mRNA expression.  Age-Related 
Locomotor Impairment Project:  Expression of PDK1, Pfrx, Doc3, m6, HLHm7 and CG14045 
was detected using SYBR Green (Quanta Biosciences) with custom primers.  For detection of 
Dp110, a Taqman assay was used (#Dm02142683_g1) with RPII140 (#Dm02134593_g1) as 
endogenous control.  Wolfram Syndrome Project: Expression of wfs2, 4E-BP, PPT1 and CLN3 
were visualized with SYBR Green (Quanta Biosciences) with custom primers.  ~800 fly heads 
were used for the PPT1 and CLN3 mRNA expression experiments.  Expression levels are 
relative to the GMR-Gal4/+ control fly.   Sod2 Candidate Suppressors Project:  Expression of 
Sod2, DJ-1α, DJ-1β and Ataxin-3 was detected using SYBR Green (Quanta Biosciences) with 
custom primers.  Primer information is listed in Table 4. 
 
1.5 Stress Tests 
Age-Related Locomotor Impairment Project:  Paraquat Survival: Males and females were 
collected for each genotype under brief CO2 anesthesia and given a period of 24 hours to 
recover.  Flies were starved for 6 hours and then placed in vials with Whatman filter disks 
saturated with 300 µl of 40mM paraquat in 5% sucrose.  The vials were placed in a humidified 
box at room temperature and the number of surviving flies in each vial was recorded after 18 
hours.  Each paraquat experiment was repeated 3 times with 6 vials of 25 flies per genotype and 
sex.  Wolfram Syndrome Project:  All flies for stress tests were collected at 1-3 days of age and  
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Table 4.   PCR Primers for qRT-PCR analyses with SYBR Green or Taqman detection. 
Gene Forward primer Reverse Primer 
PDK1 5’-CGCGACTCATCTATATCGATCC-3’ 5’-GTCAGACGCCGTCGAAGCTTG-3’ 
Pfrx 5’-CTACAGCAGCAGGAACAGC-3’ 5’-GACAGACGTGCAGCTCATTC-3’ 
Doc3 5’-CACGGGAAAACACTGGCAATC-3’ 5’-CTGGCCGAGATCAGAGGTT-3’ 
m6 5’-ACAGCTCACAAGCCGACAG-3’ 5’-CGAGTGCCAGTAGAAGCTG-3’ 
HLHm7 5’-AGTCACCGTGCAGCATCTC-3’ 5’-CAGATGGGTCATCAGTGTGG-3’ 
CG14045 5’-CAGCCGTGAAGTTCTGCTC-3’ 5’-GCAAATAGCATGAGCCGGC-3’ 
Akt 5’-GACAGACATGACAGACGTGG-3’ 
5’-GTTTACGGGAGAGAGTGTGG-3’ 
5’-GTAGCCTTCTCGCGACAC-3’ 
5’-CATCGATGCGAGACTTGTGG-3’ 
wfs2 5’- GTTGTTGCAGCGTCCGCTG-3’   5’- CGGTTCCCGACAGCATCG-3’ 
PPT1 5’- GTTCTCCATGATCGGGTCG-3’ 5’- GAGGAACCTTATCACACTCG-3’ 
 
CLN3 5’- GTACTGCGAGTCCTTGTCC-3’ 5’- GGAAGTCCTGATCAGCGATG-3’ 
 
4E-BP 5’- CATGCAGCAACTGCCAAATC-3’ 5’- CCGAGAGAACAAACAAGGTGG-3’ 
Sod2 5’- 5’-ACGAGATGTCATCCCAGTTG-3’ 5’-CAAGAAGTCGGGCAAACTGC-3’ 
DJ-1α 5’GTGATCAGGTGCAAATCCAACCAGG-3’ 5’-GGGAGCACTTCACCGGTTCAC-3’ 
DJ-1β 5’-CGGAGGAGATGGAGTTCATC-3’ 5’-CCACATCGAACTTATCCGAG-3’ 
Ataxin-3 5’-CTGACCAACTCCTGCAGATG-3’ 5’-CTTAGTGCCAGAGCCCTCTG-3’ 
Actin5c 5’-AGCGCGGTTACTCTTTCACCAC-3’ 5’-GTGGCCATCTCCTGCTCAAAGT-3’ 
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were tested for stress sensitivity at 1 and 6 weeks of age.   In each experiment, the number of 
dead flies was recorded for each stress test every 4-8 hrs until all flies were dead.  Three vials of 
25 flies each were tested for each group.  For starvation studies, flies were housed in food vials 
containing 1% agar.  For desiccation studies, flies were housed in empty vials placed in a box 
with desiccant.  To assess thermal stress, flies were placed in vials containing 1% agar with 5% 
sucrose in a 36oC incubator.  Hyperoxia studies were performed by placing flies in standard food 
vials in an air tight container charged with 95% O2 twice daily.  All drug tests compared survival 
in drug-treated and vehicle-treated food vials.  For Tunicamycin treatment, flies were placed into 
vials with food pre-treated with 100µl 2mM Tunicamycin in 95% ethanol or 95% ethanol 
(vehicle).  Flies were exposed to paraquat, FeCl3, and H2O2 by placing them in vials with 2 
Whatman paper discs treated with 300µl of 5% sucrose (vehicle) or 5% sucrose supplemented 
with 40mM paraquat, 200mM FeCl3, or 30% H2O2, respectively.  Survival in different genotypes 
or treatment groups was analyzed with log-rank tests performed using JMP 5.01.  
Sod2 Candidate Suppressors Project:  Adult males (1-3 days old) were collected with brief CO2 
anesthesia and allowed to recover for 12 hours in food vials.  For paraquat treatment flies were 
starved for 6 hours before being transferred to vials containing Whatman No. 3 filter paper with 
5% sucrose alone or with 5% sucrose supplemented with 300µl of 20 mM paraquat. For H2O2 
treatment flies were transferred to vials containing Whatman No. 3 filter paper with 5% sucrose 
alone or with 5% sucrose supplemented with 300µl of 15% H2O2.  Flies were maintained at 85% 
relative humidity/23°C throughout the experiments.  For hyperoxia treatment flies were 
transferred to fresh food vials and placed in an air tight container charged with 95% O2 3x daily.  
Surviving flies were counted every 4-8 hours after initiating paraquat, H2O2, or hyperoxia 
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treatment.  Each genotype was represented by 100-125 flies with 25 flies/vial in each 
experiment. 
 
1.6 PPT1 activity assay 
PPT1 enzyme activity levels were measured as described previously in (Buff et al., 2007).  
Briefly, a single fly head was placed in a well of a 96 well plate on ice with ~15 heads used per 
genotype.  Heads were crushed by a pestle in 30µl solution consisting of 20µl H2O and 10µl of 
the PPT1 fluorogenic substrate (4-MU-6S-palm-β-glc) and incubated for 2 hours at 30oC.  PPT1 
activity was measured by the absorbance change at 460 nm.  PPT1 loss of function flies were 
used as a negative control.  PPT1 activity data were analyzed with one-way ANOVA using JMP 
5.01. 
 
1.7 SOD activity   
Groups of 25 adult males (0-3 days old) per genotype were collected under brief CO2 anesthesia 
and homogenized in extraction buffer (50 mM potassium phosphate/0.1 mM EDTA/2% Triton-
X-100, pH 7.8) on ice.  To rupture mitochondria, samples were sonicated for 20 sec and then 
incubated at 4oC for 45 min.  Ruptured mitochondrial samples were centrifuged at 16,000 x g for 
15 min at 4oC and the resulting supernatant was stored at 4oC.  Protein concentration was 
determined using the Lowry method (DC Protein Assay, Bio-Rad). Samples containing equal 
amounts of protein were electrophoresed by Discontinuous Native PAGE (4% stacking gel (pH 
6.8), 20% resolving gel (pH 8.8) in sample buffer (0.5 M Tris-HCl/50% glycerol/0.01% 
bromophenol blue) at 80-100 V. SOD activity was measured colorimetrically using a modified 
version of an “in-gel” assay previously described (Kirby et al., 2002). Briefly, gels containing 
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electrophoresed protein samples were incubated in 2.5 mM nitroblue tetrazolium and 50 mM 
potassium phosphate buffer for 20 min in the dark under gentle agitation. Gels were washed 
briefly in 50 mM phosphate buffer and then incubated in 28 mM N,N,N’,N’-
tetramethylethylenediamine/28 µM riboflavin/50 mM potassium phosphate for 15 min in the 
dark with gentle agitation. Following a brief wash in 50 mM potassium phosphate buffer, gels 
were exposed to white light for ~15 min for full color development. In-gel SOD activity was 
quantified by densitometry using Alpha Imager software (Alpha Innotech Corp., San Leandro, 
CA).  
 
1.8 Western blots 
Protein was isolated from 25 flies per genotype by homogenization in radioimmunoprecipitation 
RIPA lysis buffer containing protease inhibitor cocktail (Roche 1:25 dilution in lysis buffer).  
Samples were sonicated, incubated on ice for 45 minutes and centrifuged at 16,000 x g for 15 
minutes at 4oC.  Supernatants were transferred to a new tube and protein concentration was 
measured using the DC Protein Assay (Bio-Rad).  Protein extracts were electrophoresed via 
SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes.  Western blots 
were probed with a rabbit anti-mouse ERIS polyclonal antibody (ProteinTech, 1:1000 dilution in 
5% BSA in tris-buffered saline solution containing 0.1% Tween-20  (TBST) to detect 
Drosophila WFS2 (dWFS2) or a mouse anti-α tubulin monoclonal antibody (Sigma, 1:1000 
dilution in 5% milk in TBST) to detect the loading control.  Expression of dWFS2 and α-tubulin 
was visualized with goat anti-rabbit IgG-HRP (BioRad, 1:10,000 dilution in 5% milk in TBST) 
and goat anti-mouse IgG-HRP (Santa Cruz, 1:10,000 dilution in 5% milk in TBST), respectively, 
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in conjunction with Western Lightning chemiluminescence reagent plus (PerkinElmer). Western 
blot experiments were repeated three times with independent protein extracts. 
 
1.9 Eye area mesurements 
The area of the eye was measured using Scion Image.  5 fly heads were cut off for each genotype 
and a line was manually drawn around the perimeter of the eye.  The area within this perimeter 
in mm2 was determined by Scion image.  Flies that were collected for each genotype were 
generally the same whole body size and flies with obvious differences in whole body size were 
discarded.  
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Chapter 2 
 
A forward genetic screen in Drosophila implicates insulin signaling in age-related 
locomotor impairment 
 
 
1. Introduction 
 
Aging in humans and other species is characterized by a number of progressive functional 
declines (Arking, 1998).  Age-related locomotor impairments (ARLI) are particularly 
problematic in this regard.  Patients with impaired locomotor abilities have reduced physical 
activity levels (Pahor et al., 2006), are less independent and require more clinical care (Boyd et 
al., 2005), are at much greater risk for being institutionalized (von Bonsdorff et al., 2006), and 
are at greater risk for depression (Braam et al., 2005).  Additionally, ARLI is associated with an 
increased risk for falling and skeletal fractures as well as a variety of co-morbidities including 
coronary artery and cerebrovascular diseases, obesity, diabetes and hypertension (Boyd et al., 
2005; Hillsdon et al., 2005; Onder et al., 2005; Volpato et al., 2005; Cesari et al., 2006a; Cesari 
et al., 2006b).  ARLI is therefore a significant clinical challenge for elderly patients and their 
caregivers. 
 
ARLI occurs in rodents (Forster et al., 1996) and flies (Grotewiel et al., 2005) in addition to 
humans (Walston et al., 2006).  ARLI is associated with age-dependent decreases in muscle mass 
and walking speed in vertebrates (Arking, 1998; Woo et al., 1999) as well as in Drosophila 
(Baker, 1976; Sohal, 1985; Rhodenizer et al., 2008).  Additionally, oxidative damage might be 
an underlying cause of ARLI in humans (Nikolic et al., 2005) and flies (Bhandari et al., 2007).  
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These parallels raise the possibility that ARLI might be driven by common mechanisms in 
invertebrates and mammals.   
 
Our laboratory has developed an assay called Rapid Iterative Negative Geotaxis (RING) for 
assessing locomotor function in flies (Gargano et al., 2005).  Negative geotaxis (i.e. startle-
induced climbing) is a legged locomotor behavior that becomes impaired with age due to an age-
dependent decrease in climbing speed (Rhodenizer et al., 2008).  Studies from our laboratory 
using RING assays show that flies with mutations in the insulin signaling gene chico, the 
metabolite transporter gene Indy, and the olfactory receptor gene Or83b have slowed ARLI 
(Gargano et al., 2005; Martin and Grotewiel, 2006; Rhodenizer et al., 2008).  Additional studies 
from our laboratory show that RNAi-mediated knock-down of SOD2, a major mitochondrial 
antioxidant, accelerates ARLI (Bhandari et al., 2007).  These studies support a role for insulin 
signaling, metabolism, environmental sensing and oxidative damage in ARLI.   
 
A more complete understanding of the genes and genetic pathways that influence ARLI would 
greatly facilitate the development of interventions that mitigate the effects of age on locomotor 
ability.  To this end we performed a forward genetic screen for P-element insertions that forestall 
ARLI in Drosophila.  We identified a number of transposon insertion strains with delayed ARLI 
including a strain with a P-element insertion in the gene phosphoinositide-dependent kinase 1 
(PDK1) that reduced expression of the gene’s mRNA.  Additional studies with this and other loss 
of function alleles in PDK1 in conjunction with loss of function alleles in two other insulin 
signaling genes, Dp110 and Akt, confirmed a role for insulin signaling in ARLI.   
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2. Results 
 
2.1 Identification of delayed ARLI mutants 
We performed a forward genetic screen to identify P-element insertions in Drosophila that delay 
age-related locomotor impairment (ARLI).  We used a Rapid Iterative Negative Geotaxis 
(RING) assay previously developed by our laboratory (Gargano et al., 2005) to assess ARLI  
throughout the screen and for all follow-up studies.  We tested only males in our screen toward 
limiting the potential confounding effects of reproduction on aging in female flies (Chapman et 
al., 1995; Sgro and Partridge, 1999; Partridge et al., 2005).  We screened a total of 729 EP 
(Rorth, 1996) and 364 pGawB (Seroude et al., 2002) transposon insertions.  Although EP and 
pGawB elements have various uses in Drosophila, we focused on their ability as transposons to 
disrupt the function of a gene when inserted nearby (Stoltzfus et al., 2003).  We went through 
two rounds of screening to isolate P element insertions that consistently had delayed locomotor 
impairment across age.  The putative insertions that consistently had delayed locomotor decline 
were backcrossed to our w[cs] control fly for 7 generations to control for genetic background 
effects on behavior and aging (Cook-Wiens and Grotewiel, 2002; Goddeeris et al., 2003; 
Gargano et al., 2005; Bhandari et al., 2006; Bhandari et al., 2007).  After testing to confirm that 
the locomotor behavior was consistently delayed after backcrossing we were left with 7 P 
element insertions strains for further study (Figure 1A and B). 
 
We mapped or confirmed the location of the transposon insertions in all of the strains with 
delayed ARLI via inverse PCR or standard PCR, respectively (primer information provided in 
Table 3).  EP837 is inserted in the transcription unit of phosphoinositide-dependent kinase 1 
(PDK1, a.k.a. CG1210, Figure 2A), a gene within the canonical insulin signaling pathway  
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Figure 1.  Delayed ARLI in backcrossed EP and pGawB insertion lines. Negative geotaxis 
was measured at weekly intervals in control (w[cs]) and the indicated EP (837, 1150 and 1174) 
and pGawB (DJ708, DJ913, DJ996 and DJ1026) insertion lines (A and B). Negative geotaxis 
declined with age in all strains tested (two-way ANOVA, p < 0.0001). All EP and pGawB 
insertion lines shown performed significantly better than w[cs] controls (individual two-way 
ANOVAs, p < 0.0001). Data (mean ± SEM, n = 10–15) are from 2 to 3 independent 
experiments.  Experiments were performed by Devin Rhodenizer and Pretal Patel. 
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Figure 2.  Transposon insertion sites in flies with delayed ARLI.  In all panels, transcription 
units are indicated by black boxes, protein-coding exons by open boxes, and untranslated regions 
by grey-filled boxes.  P-elements are depicted as triangles with arrows indicating their 5’-3’ 
orientation.  Scale bars in the upper right-hand corner of each panel are 1 kb.  Schematics of 
exons, introns and transcripts are based on information from FlyBase (http://flybase.org).  (A) 
PDK1 with EP insertions 837 and 3553 in addition to GT1 insertion BG02759.  (B) Pfrx with EP 
insertion 1150. (C) Doc3 with pGawB insertion DJ708.    (D) m6 and HLHm7 region with 
pGawB insertions DJ996, DJ1026 and DJ913.  (E) CG14045 with EP insertion 1174.  (F) Dp110 
with PiggyBac insertions c00368 and e03435.  (G) Akt with PiggyBac insertion c00298.  All 
pGawB insertion sites were identified by inverse PCR.  All other transposon insertion sites were 
confirmed by PCR using genomic DNA as template.  
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(Taniguchi et al., 2006).   EP1150 is inserted within 6-phosphofructo-2-kinase (Pfrx, a.k.a. 
CG3400, Figure 2B).  Pfrx encodes a key, highly conserved enzyme (6-phosphofructo-2-kinase) 
involved in gluconeogenesis (Rider et al., 2004).  DJ708 is inserted upstream of Dorsocross3 
(Doc3, a.k.a. CG5093, Figure 2C), a gene that encodes a T-box transcription factor involved in 
wingless and decapentapalegic signaling (Reim et al., 2003; Hamaguchi et al., 2004; Reim and 
Frasch, 2005).  Three pGawB transposon insertions (DJ913, DJ1026 and DJ996) are inserted 
between the genes m6 and HLHm7 (Figure 2D).  The m6 locus encodes a 70 amino acid protein 
of unknown function found only in the Drosophila genus (FLYBASE.BIO.INDIANA.EDU).  HLHm7 
(a.k.a. E(spl)m7 or m7) encodes a helix-loop-helix transcription factor of the enhancer of split 
family (Klambt et al., 1989; Ligoxygakis et al., 1999).  EP1174 (Figure 2E) is inserted near 
CG14045 which encodes a predicted GTPase activating protein (GAP) for Rho G proteins 
(FLYBASE.BIO.INDIANA.EDU).  Based on BLAST searches (Altschul et al., 1997), the GAP 
encoded by CG14045 is found in insects but not other animals. 
 
We performed quantitative real-time PCR (qRT-PCR) analyses to determine whether the EP and 
pGawB insertions that delayed ARLI were associated with altered expression of nearby genes 
(primer information provided in Table 4).  Compared to w[cs] controls, expression of PDK1 and 
Pfrx were decreased by 25% in EP837 and 92% in EP1150, respectively (Table 5).  In contrast, 
expression of Doc3 was increased by ~8-fold in DJ708 (Table 5).  Thus, EP837 and EP1150 are 
partial loss of function mutations in PDK1 and Pfrx, respectively, whereas DJ708 is a gain of 
function allele of Doc3.  These three alleles are designated PDK1EP837, PfrxEP1150 and Doc3DJ708 
hereafter.  We analyzed PDK1EP837 and other insulin signaling mutants as described below.  The 
lab is currently analyzing PfrxEP1150 and Doc3DJ708 and results will be published at a later date.   
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Table 5:  Gene expression in transposon insertion lines.  Expression of genes (column 1) 
harboring transposon alleles (column 2) was assessed via qRT-PCR.  Data (mean ± S.E.M., n in 
parentheses) are percent change in expression (column 3) relative to expression in w[cs] controls.  
Negative and positive values indicate decreases and increases in expression, respectively.  All of 
the transposons significantly altered expression of their respective genes (column 4, one-sample 
t-test). 
 
Gene Genotype Expression p Value
PDK1 EP837 -25.3 ± 3.5 (11) < 0.001 
 EP3553 -8.0 ± 2.9 (6) 0.041 
 BG02759 -21.4 ± 2.1 (5) 0.001 
    
Pfrx EP1150 -92.3 ± 0.9 (3) < 0.001 
    
Doc3 DJ708 818 ± 118 (6) < 0.001 
    
Dp110 c00368 -15.9 ± 5.1 (6) 0.026 
 e03435/+ -27.5 ± 2.1 (3) 0.006 
    
Akt c02098/+ -38.6 ± 4.3 (4) 0.003 
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Despite repeated efforts, we did not consistently detect a change in expression of CG14045 in 
EP1174 adult flies.  Similarly, we did not find a consistent change in expression of either m6 or 
HLHm7 in DJ913, DJ996 or DJ1026 adult flies.  It is possible that expression of these genes 
might be altered during a limited number of developmental stages or altered in a subset of 
tissues.  Nevertheless, we provide preliminary data on these P-element insertion strains in the 
interest of fully reporting the results of our screen and because these strains facilitated our 
investigation of the relationship between paraquat resistance and ARLI. 
 
2.2 Insulin signaling and delayed ARLI 
PDK1 is a component of the canonical insulin signaling pathway (Taniguchi et al., 2006).  The 
insulin signaling pathway is conserved across species (Figure 3).  The insulin signaling pathway 
is stimulated when insulin or insulin like peptides bind the cell surface receptor InR.  InR then 
phosphorylates its substrate chico.  The insulin signaling pathway continues down a 
phosphorylation cascade through PI3K, PDK1, AKT, and FOXO.  When FOXO is 
phosphorylated by AKT it is sequestered in the cytoplasm.  When FOXO is not phosophorylated 
(i.e. under conditions of low insulin signaling) it translocates to the nucleus, thereby regulating 
expression of a number of genes.  The delayed ARLI in PDK1EP837 flies (Figure 1A) suggested 
that insulin signaling might influence this aspect of aging.  We explored this possibility by 
further investigating the role of PDK1 and other insulin signaling genes. 
 
To address whether the EP837 insertion was responsible for the delayed ARLI in PDK1EP837 
flies, we assessed negative geotaxis across age in revertant flies (PDK1EP837rv4 and PDK1EP837rv9) 
with wild type chromosomes derived from precise excision of the EP837 transposon insertion.   
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Figure 3.  The insulin signaling pathway in Drosophila, C. elegans and Mammals.  
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Precise excision of EP837 returned PDK1 expression to normal in both revertant lines (one 
sample t tests, n = 5-6, n.s.).  ARLI was indistinguishable in w[cs] and both revertant lines, 
whereas it was significantly delayed in PDK1EP837 flies compared to these three controls (Figure 
4).    These results demonstrate the EP837 insertion in PDK1 causes delayed ARLI. PDK1 
functions immediately downstream of phosphatidylinositol 3-kinase (PI3K) and immediately 
upstream of AKT in the canonical insulin signaling pathway (Taniguchi et al., 2006).  Based on 
the reduced expression of PDK1 in EP837 flies (Table 5), we reasoned that additional partial loss 
of function alleles in PDK1 and other insulin signaling genes might also delay ARLI.  We 
therefore characterized two additional transposon insertions in PDK1 (EP3553 and BG02759, 
Figure 2A), two transposon insertions in Dp110 (a.k.a. CG4141, the gene that encodes the 
catalytic subunit of PI3K, Figure 2F), and a transposon insertion in Akt (a.k.a. CG4006, the gene 
that encodes AKT, Figure 2G).  The insertion sites for all transposons in or near these genes 
were confirmed by standard PCR.  All transposons were subsequently backcrossed for seven 
generations to w[cs] to control for genetic background effects on behavior  
and aging.  qRT-PCR studies indicated that these additional five transposon insertions cause 
partial loss of function in their respective genes (Table 5).  These strains are designated as 
PDK1EP3553, PDK1BG02759, Dp110c00368, Dp110e03435, and Aktc02098. 
 
To address whether additional partial loss of function alleles in PDK1 and whether partial loss of 
function in Dp110 and Akt delay ARLI, we assessed negative geotaxis across age in w[cs] 
controls and PDK1EP3553, PDK1BG02759, Dp110c00368, Dp110e03435/+, and Aktc02098/+ flies.  We 
evaluated males and females in these studies because mutations in insulin signaling genes have 
sex-specific effects on life span (Burger and Promislow, 2004).  Negative geotaxis across age 
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 Figure 4.  ARLI in PDK1EP837 and revertants.  Negative geotaxis in w[cs], the revertants 
PDK1EP837rv4 and PDK1EP837rv9, and PDK1EP837 flies. Age and genotype affected negative 
geotaxis (two-way ANOVA, p<0.0001 for both factors).  The w[cs] control (open circles) and 
revertants (PDK1EP837rv4, open squares; PDK1EP837rv9,open triangles) performed 
indistinguishably, while the PDK1EP837 (filled circles) flies performed better (Tukey HSD 
p<0.05).  Data (mean ± SEM) are from two experiments with 5 vials of 25 flies per genotype in 
each experiment. 
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declined in all genotypes as expected (Figure 5).  Negative geotaxis was elevated relative to 
w[cs] controls in PDK1EP3553 and PDK1BG02759 males (Figure 5A) and females (Figure 5B).  
Negative geotaxis across age was also elevated in Dp110c00368 males and females and in 
Dp110e03435/+ females (Figure 5C and 5D).  Aktc02098/+ males and females also had enhanced 
negative geotaxis across age (Figure 5E and 5F).  Our studies show that partial loss of function 
mutations in multiple insulin signaling genes delay ARLI in flies. 
 
2.3 Paraquat resistance and delayed ARLI 
Increased resistance to exogenously applied oxidative stress is associated with extended life span 
in Drosophila (Lin et al., 1998; Tatar et al., 2001; Wang et al., 2004; Walker et al., 2006).  We 
investigated whether the delayed ARLI in the transposon insertion strains used in our studies 
might be associated with altered oxidative stress resistance and assessed survival in flies fed 
paraquat, a strong oxidative stressor (Kirby et al., 2002).  Paraquat survival was enhanced in all 
the transposon insertion lines recovered from our screen including the EP837 P element insertion 
(Figure 6A).  In contrast, additional studies with other alleles of PDK1 and alleles of Dp110 and 
Akt revealed that only PDK1BG02759 males had enhanced paraquat survival compared to w[cs] 
control flies (Figure 6B).  In females, none of the additional PDK1, Dp110 or Akt mutants tested 
had significantly altered paraquat survival (Figure 6C).  Although elevated paraquat survival was 
observed in many transposon lines with delayed ARLI, enhanced resistance to this oxidative 
stressor is not required for the preservation of locomotor function across age. 
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Figure 5.  Delayed ARLI in insulin signaling mutants.  Negative geotaxis across age in males 
(A, C, and E) and females (B, D and F) flies with mutations in PDK1 (A and B), Dp110 (C and 
D) and Akt (E and F).  Age and genotype affected negative geotaxis in all experiments 
(individual two-way ANOVAs, p<0.0001 for both factors).  Individual Tukey HSD multiple 
comparison tests revealed that negative geotaxis was increased compared to w[cs] in all insulin 
signaling mutants except Dp110e03435/+ males (C).  Data (mean ± SEM) are compiled from two 
experiments with 5 vials of 25 flies per genotype in each experiment. 
 
 52
 Figure 6.  Paraquat survival in EP and pGawB insertion lines with delayed ARLI.  Survival 
at 18 hours in the presence of 40mM paraquat was assessed in the indicated genotypes.  (A) 
Genotype had a significant effect on survival of males (one-way ANOVA, p=0.0006, n=3).  All 
transposon alleles survived significantly longer than w[cs] (*Bonferroni’s multiple comparison 
test, p<0.05).  (B) Paraquat survival in male insulin signaling mutants was significantly affected 
by genotype (one-way ANOVA, p=0.0111).  Only PDK1BG02759 flies survived longer than w[cs] 
controls (*Bonferroni’s multiple comparison test, p<0.05).  (C) Genotype had no significant 
effect on paraquat survival in female insulin signaling mutants (one-way ANOVA, n.s.). 
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3. Discussion 
Aging is associated with progressive impairments in a number of physiological and cognitive 
functions (Arking, 1998).  Among the functional deficits that occur during aging, ARLI is 
particularly significant because it is associated with increased rates of falls, fractures and 
institutionalization in humans (Boyd et al., 2005; Pahor et al., 2006; von Bonsdorff et al., 2006).   
Identifying genes and genetic pathways that influence age-related changes in locomotor ability 
and other functions is critical for developing treatment strategies that mitigate the effects of age 
on health status.  Here, we report the results of our studies in Drosophila that investigate the 
genetic basis of ARLI. 
 
Through a forward genetic strategy, we identified seven transposon insertion lines with age-
dependent preservation of negative geotaxis, a startle-induced locomotor behavior (Rhodenizer 
et al., 2008).  One of the lines with delayed ARLI has a transposon insertion in PDK1 that 
reduces expression of this gene.  Removal of the transposon insertion via precise excision 
restores normal expression of PDK1 and eliminates the delayed ARLI phenotype in these flies 
suggesting that PDK1 and, more generally, insulin signaling influence this aspect of aging.  
Consistent with this possibility, ARLI is delayed in flies with other partial loss of function alleles 
of PDK1 and in flies with partial loss of function mutations in two additional insulin signaling 
genes, Dp110 and Akt.  Furthermore, our laboratory previously reported that mutation of chico, 
which encodes an insulin receptor substrate in Drosophila, also forestalls ARLI (Gargano et al., 
2005).  All of these data support a role for the insulin signaling pathway in regulating the effects 
of age on locomotor function in flies. 
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Disruption of insulin signaling has a number of positive effects on aging in diverse species.  An 
extensive literature demonstrates that loss of function mutations in key genes within the pathway 
extend life span in worms, flies and mice (Kenyon, 2001; Tatar et al., 2003a).  Additionally, 
extended life span in humans is associated with polymorphisms in the genes that encode the 
insulin/insulin like growth factor receptor (Suh et al., 2008) and FOXO3A (Willcox et al., 2008), 
a downstream effector of the pathway.  Importantly, though, the effects of the insulin signaling 
pathway on aging extend beyond its influence on life span.  Mutations that disrupt insulin 
signaling in C. elegans delay senescence of pharyngeal pumping and body movements (Huang et 
al., 2004) and age-related decline in associative memory (Murakami et al., 2005).  Additionally, 
genetic manipulations that blunt insulin signaling delay cardiac aging in Drosophila (Wessells et 
al., 2004).  The studies reported here and our previous studies on chico mutants (Gargano et al., 
2005) demonstrate that the insulin signaling pathway also influences ARLI in flies.  Given that 
the insulin signaling pathway appears to have conserved effects on life span in diverse species, it 
would be extremely interesting to determine whether this pathway is also involved in the 
preservation of locomotor function in mammals including humans. 
 
Data from our screen also suggest that genes outside of the insulin signaling pathway might be 
important for ARLI.  Three strains with delayed ARLI contain P-elements inserted between the 
genes m6 and HLHm7.  Additionally, other delayed ARLI strains contain P-element insertions 
near the genes CG14045, Pfrx and Doc3.  While it is tempting to speculate that m6, HLHm7, 
CG14045, Pfrx or Doc3 might influence ARLI, these effects must be formally validated before 
definitive connections can be made regarding the role of these genes in locomotor senescence.   
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Oxidative damage is thought to play a role in ARLI in humans (Nikolic et al., 2005) as well as 
flies (Bhandari et al., 2007).  Consistent with this possibility, many of the transposon insertions 
with delayed ARLI have elevated resistance to the oxidative stressor paraquat.  Several other 
insertion lines with delayed ARLI, however, have no change in their paraquat survival.  These 
data indicate that while enhanced resistance to paraquat can accompany preservation of 
locomotor function across age, the enhanced resistance is not required.  Additional studies will 
be necessary to fully delineate the role of oxidative stress resistance in ARLI.  Determining 
whether overexpression of antioxidant genes that compat oxidative stress forestalls ARLI will be 
important for assessing if this mechanism is important for preserving locomotor function across 
age.   
 
A number of manipulations that extend life span in Drosophila and other species have sex-
specific effects (Burger and Promislow, 2004).  For example, mutations in Drosophila that blunt 
insulin signaling produce a larger life span increase in females as compared to males (Tatar et al., 
2001; Tu et al., 2002).  Additionally, dietary restriction (defined as reduced food intake without 
malnutrition) causes a greater extension of life span in female versus male flies (Magwere et al., 
2004).  Interestingly, preservation of locomotor function across age does not strictly follow this 
same pattern.  While the effects of mutations in Dp110 and Akt are more robust in females than 
in males, the opposite is true for mutations in PDK1.  Additional studies will be necessary to 
formally address whether genetic and other manipulations that preserve locomotor or other 
functions across age have predictable sex-specific effects in flies and mammals as found for life 
span.  For example, testing of females and males in learning and memory assays, odor avoidance 
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assays, circadian behavior, reproduction, and cardiac senescence will reveal whether these age-
related changes have sex-specific effects.   
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Chapter 3 
 
Wolfram syndrome 2 (wfs2) is a novel genetic modifier of the lysosomal storage disease  
genes PPT1 and CLN3 in Drosophila 
 
1. Introduction 
Wolfram Syndrome is an autosomal recessive neurodegenerative disease that affects 1 in 
770,000 people in the UK (Barrett et al., 1995).  Affected individuals present with diabetes 
mellitus, diabetes insipidus, optic atrophy and deafness (DIDMOAD) (Wolfram, 1938).  Other 
features of this syndrome include psychiatric illness (Strom et al., 1998) and renal-tract 
abnormalities (Barrett et al., 1995).  Patients usually die within the 3rd decade of life due to 
respiratory failure associated with brainstem atrophy (Scolding et al., 1996).  Mutations in two 
genes, WFS1 and CISD2 (Strom et al., 1998; Amr et al., 2007) and are known to cause Wolfram 
Syndrome.  WFS1 encodes wolframin, a transmembrane protein that localizes to the ER.  
Wolframin is important for intracellular calcium homeostasis and is a downstream component of 
IRE1 and PERK signaling in the unfolded protein response (Osman et al., 2003; Fonseca et al., 
2005).   
 
CISD2, the second Wolfram Syndrome locus, was more recently identified (Amr et al., 2007).  A 
splice site mutation in CISD2 that eliminates the full-length transcript was identified in three 
Jordanian families with Wolfram Syndrome (Amr et al., 2007).  The CISD2 gene encodes ERIS 
(endoplasmic reticulum intermembrane small protein), a protein with a single predicted 
transmembrane domain and a single predicted iron-sulfur domain (Amr et al., 2007; Wiley et al., 
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2007).  ERIS localizes to the ER and, like wolframin, could be involved in regulating the 
unfolded protein response (Amr et al., 2007).  A more recent study found that knock-out of 
Cisd2 in mice recapitulates at least some features of Wolfram Syndrome in humans (Chen et al., 
2009).   For example, Cisd2 knock-out mice exhibit neurodegeneration in conjunction with 
shortened lifespan.  These mice also have mitochondrial degeneration, suggesting that ERIS is 
important for mitochondrial integrity and that mitochondrial dysfunction might contribute to the 
pathology of Wolfram Syndrome (Chen et al., 2009).  It was also recently discovered that Cisd2 
functions within an autophagy pathway mediated by Beclin-1(Chang et al., 2009).  Despite these 
and other advances in understanding ERIS (the Cisd2 gene product), however, its function or 
functions have not been fully resolved. 
 
Here, we describe genetic studies in the fruit fly, Drosophila melanogaster, to provide insight 
into the function of wfs2, the fly orthologue of CISD2.  We investigated whether decreased 
expression of wfs2 had deleterious consequences in Drosophila.   In addition, we investigated 
whether knocking down wfs2 expression in the eye modified the phenotype of a number of 
different genetic models related to neurodegeneration.  Although knockdown of wfs2 by itself in 
flies had no obvious effect on a number of divergent phenotypes, we found that decreased 
expression of wfs2 modified the degenerative eye phenotypes caused by overexpression of two 
lysosomal storage disease genes, PPT1 and CLN3.  Additional studies indicated that PPT1 and 
CLN3 are functionally related.  Our data support a model in which wfs2 might function in 
concert with PPT1 and CLN3 under normal or possibly pathological states.   
 
2. Results 
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2.1 Identification and manipulation of Drosophila wfs2 
BLASTp searches identified Drosophila CG1458 as a potential orthologue of human CISD2.    
The CG1458 predicted gene product is 46% identical and 68% similar overall to human ERIS.  
Both proteins are very similar in size (135 and 133 amino acids, respectively), have the same 
predicted topology (Figure 7A), and contain a single predicted transmembrane domain (Figure 
7A) and a single predicted CDGSH iron sulfur domain at the same positions (Figure 7B).  The 
conservation in predicted primary amino acid sequences, protein sizes, transmembrane domain 
number and positions, and overall topologies indicate that CG1458 is likely orthologous to 
human CISD2.  Considering these data and that we found no other predicted Drosophila proteins 
with significant homology to ERIS, we have designated CG1458 as wfs2. 
 
To manipulate wfs2 expression, we used the Gal4-UAS system to drive two wfs2 RNAi 
transgenes (obtained from the Vienna Drosophila Research Center).  We performed quantitative 
real-time PCR (qRT-PCR) analyses to determine if these RNAi transgenes knocked down wfs2 
mRNA expression.  da-Gal4-driven ubiquitous expression of UAS-wfs2-RNAi transgenes 33925 
(WFS2.1) and 33926 (WFS2.2) decreased wfs2 mRNA levels by at least 95%.  Additionally, a 
band consistent with dWFS2 protein was readily detectable in extracts from control flies on 
Western blots using an ERIS polyclonal antibody (Figure 8A).  This band was undetectable, 
however, in flies with ubiquitous expression of wfs2 RNAi (Figure 8A).  These qRT-PCR and 
Western blot results indicate that expression of the wfs2 RNAi transgenes causes a strong loss of 
function in wfs2, although they do not preclude the possibility that some residual expression of 
wfs2 remains in these animals. 
2.2 Knockdown of wfs2 alone does not have obvious detrimental effects in Drosophila  
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Figure 7.  Conserved structure of ERIS and dWFS2.  (A) Hydropathy plots for human ERIS 
(i) and dWFS2 (ii).  Amino termini are on the left.  Predicted transmembrane domains (TMpred 
at embnet) are indicated by arrows.  (B) Comparison of the primary amino acid sequences for 
human ERIS and dWFS2.  Gaps are represented by asterisks (*).  Identical amino acids are in 
bold.  The single underline represents the predicted transmembrane domains.  The double 
underline represents the CDGSH domains. 
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Figure 8.  Ubiquitous knockdown of wfs2 is not associated with obvious detrimental effects.    
(A) Knockdown of dWFS2 protein.  dWFS2 protein was robustly detected with anti-CISD2 
antisera in extracts from control animals (da/+, WFS2.1/+ and WFS2.2/+) whereas it was 
undetectable in extracts from wfs2 knockdown flies (da/WFS2.1 and da/WFS2.2).  Top panel, 
dWFS2; bottom panel, α-tubulin loading control.   (B) Expression of wfs2 RNAi transgenes 
using GMR-Gal4 had no effect on the external eye morphology.  Light microscope images of 
eyes in representative flies with genotype (i) GMR-Gal4/+ control, (ii) GMR-Gal4/WFS2.1, and 
(iii) GMR-Gal4/WFS2.2.  (C) Survival under normal housing conditions in males was not altered 
by ubiquitous expression of WFS2.1 RNAi (da-Gal4/WFS2.1) compared to controls (WFS2.1/+, 
da-Gal4/+) (log-rank test, n.s.).  (D) Ubiquitous knockdown of wfs2 (da-Gal4/WFS2.1) did not 
alter locomotor performance (negative geotaxis) across age compared to controls (da-Gal4/+, 
WFS2.1/+) (two-way ANOVA, n.s.). 
 
 62
Toward investigating the role of wfs2 in Drosophila, we determined whether knocking down its 
expression in several tissues via the Gal4-UAS system (Brand and Perrimon, 1993) led to 
obvious phenotypes in flies reared and aged under normal housing conditions.  Expression of 
wfs2 RNAi in the eye via GMR-Gal4 (Freeman, 1996) had no discernable effect on external eye 
morphology (Figure 8B).  Similarly, knockdown of wfs2 throughout the body (Figure 8C and D, 
da-Gal4 and Actin-Gal4, Table 6), in the musculature (mef2-Gal4, Table 6,), or in the nervous 
system (188Y-Gal4 and Appl-Gal4, Table 6,) had no obvious effects on lifespan or age-related 
locomotor impairment.  Additionally, knockdown of wfs2 ubiquitously (da-Gal4), in the 
musculature (mef2-Gal4) or in the nervous system (Appl-Gal4) did not lead to a change in bang 
sensitivity, an index of seizure susceptibility (Fergestad et al., 2006), in 1-8 week-old flies (Table 
6).  Ubiquitous knockdown of wfs2 via da-Gal4 had no significant effect on expression of 4E-BP 
at 1 or 8 weeks of age (Table 6), suggesting that insulin signaling was not impaired in these 
animals (Fuss et al., 2006).  Thus, knockdown of wfs2 via a number of Gal4 drivers does not 
appear to have major negative consequences on the measures we assessed in flies housed under 
normal laboratory conditions. 
 
To address whether wfs2 might be important for stress sensitivity, we evaluated whether 
ubiquitous knockdown of wfs2 altered survival when flies were exposed to thermal, desiccation, 
starvation, oxidative (hyperoxia, paraquat and H2O2), FeCl3 (iron overload) and tunicamycin 
(ER) stress.  We assessed survival of flies at 1 and 6 weeks of adulthood to address the 
possibility that effects of wfs2 knockdown could manifest with age.  Although we occasionally 
saw subtle effects of ubiquitous knockdown of wfs2 on stress sensitivity in individual 
experiments, these effects were not consistently observed (Table 6).  Additionally, expression of   
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Table 6.  Knock-down of wfs2 does not cause detrimental effects in Drosophila.  Expression 
of the WFS2.1 RNAi transgene ubiquitously (da-Gal4, Actin-Gal4), in the muscle (mef2-Gal4) 
or in the nervous system (188Y-Gal4, Appl-Gal4) had no consistent effect on behavior, lifespan, 
stress sensitivity, or external eye morphology. 
 
Experiment Gal4 Driver Ages Tested 
Behavior   
     Negative Geotaxis da, Actin, mef2, 188Y, Appl Week 1, 3, 5, and 7 
     Bang Sensitivity (seizures) da, mef2, Appl  Weeks 1-8 
   
Longevity   
     Lifespan da, Actin, mef2, 188Y, Appl  
   
Insulin Regulation   
     4E-BP expression analysis da Weeks 1 and 8 
   
Stress Sensitivity   
     Thermal da  Weeks 1 and 6 
     Desiccation da  Weeks 1 and 6 
     Starvation da  Weeks 1 and 6 
     Hyperoxia (oxidative stress) da, Appl Week 6 
     Paraquat (oxidative stress) da  Weeks 1 and 6 
     H2O2 (oxidative stress) da, Appl Week 1  
     FeCl3 (iron overload) da, Appl Week 1  
     Tunicamycin treatment (ER stress) da, Actin, mef2, 188Y, Appl Weeks 1 and 6 
   
Development/Degeneration   
     External Eye Morphology GMR Weeks 1 and 6 
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wfs2 RNAi selectively in the nervous system and musculature had no consistent effect on 
sensitivity to exogenous stressors (Table 6).  Knockdown of wfs2, therefore, had no discernable 
effect on sensitivity to any of the stressors we tested. 
 
2.3 Targeted genetic analysis identifies a novel interaction between wfs2 and the lysosomal 
storage disease gene PPT1 
Given that mutations in CISD2 cause neurodegeneration in Wolfram Syndrome, we postulated 
that wfs2 might interact with genes known or predicted to cause neuropathology in flies.  We 
therefore assessed whether GMR-driven expression of wfs2 RNAi modified the phenotypes in 
several genetic models of neurodegeneration (autosomal dominant retinitis pigmentosa, ataxia 
telangiectasia, Parkinson disease, Alzheimer disease, etc.).  Additionally, we determined whether 
GMR-driven expression of wfs2 RNAi led to a synthetic phenotype in conjunction with altered 
cellular processes associated with pathology (oxidative stress, apoptosis and autophagy) (Table 
7).  We evaluated external eye morphology at 1 and 6 weeks of age to address the possibility that 
wfs2 knockdown could have age-dependent modifier effects.   
 
Knockdown of wfs2 appeared to modify the external eye morphology in two strains that 
overexpressed wild-type palmitoyl-protein thioesterase 1 (PPT1), but had no discernable effect 
in any of the other strains tested.  Overexpression of PPT1 in the Drosophila eye causes 
blackened ommatidia thought to be indicative of apoptosis (Korey and MacDonald, 2003).  
Mutations in PPT1 cause infantile neuronal ceroid lipofuscinosis (INCL), a severe pediatric 
neurodegenerative disease resulting in death by 10 years of age (Vesa et al., 1995).   
Table 7.  Candidate interactors for wfs2.  Candidates (UAS transgenes or mutants, column 1) associated with several 
different human diseases or pathological processes (column 3) were crossed to flies expressing wfs2 RNAi in the eye 
(GMR-WFS2.1).  The effects of wfs2 RNAi on the external eye morphology associated with expression of the transgenes 
in column 1 were assessed at 1 and 6 weeks of age (see main text). 
 
Candidate     Class Associated disease/
Pathological process 
Source Citation
UAS-PPT1 2.1  ectopic 
expression  
Infantile neuronal ceroid 
lipofuscinosis (INCL) 
Christopher Korey, 
Charleston, SC 
(Korey and 
MacDonald, 2003) 
 
 
   
   
    
  
    
    
    
    
UAS-PPT1 8.1  ectopic 
expression  
 
Infantile neuronal ceroid 
lipofuscinosis (INCL) 
 
Christopher Korey, 
Charleston, SC 
 
(Korey and 
MacDonald, 2003) 
 
ninaE RH27 mutant  Autosomal dominant retinitis 
pigmentosa 
 
Hermann Steller, New 
York, NY 
 
(Ryoo et al., 2007) 
ninaE G69D mutant Autosomal dominant retinitis 
pigmentosa 
 
Hermann Steller, New 
York, NY 
 
(Ryoo et al., 2007) 
UAS-pATMT4-
RNAi 
knockdown Ataxia telangiectasia Stacey Rimkus, 
Madison, WI 
 
(Rimkus et al., 2008) 
UAS-α-synuclein ectopic
expression  
 
Parkinson disease Mel Feany, Boston, MA (Feany and Bender, 
2000) 
UAS-α-synuclein-
A30P 
ectopic 
expression  
 
Parkinson disease Mel Feany, Boston, MA (Feany and Bender, 
2000) 
UAS-α-synuclein-
A53T 
ectopic 
expression  
 
Parkinson disease Mel Feany, Boston, MA (Feany and Bender, 
2000) 
UAS-DJ-1α-RNAi  knockdown Parkinson disease Bingwei Lu, Palo Alto, 
CA 
(Yang et al., 2005) 
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UAS-Pink1-RNAi knockdown Parkinson disease Rolf Bodmer, La Jolla, 
CA 
(Wang et al., 2006a) 
UAS-GCC90-
EGFP 
ectopic 
expression  
 
Fragile X associated tremor and 
ataxia syndrome 
 
Juan Botas, Houston, 
TX 
(Jin et al., 2003) 
UAS-GCC90-14J ectopic
expression  
 
Fragile X associated tremor and 
ataxia syndrome 
 
Juan Botas, Houston, 
TX 
(Jin et al., 2003) 
UAS-GCC90-20J ectopic
expression  
 
Fragile X associated tremor and 
ataxia syndrome 
 
Juan Botas, Houston, 
TX 
(Jin et al., 2003) 
UAS-dUBQN ectopic
expression  
 
Alzheimer disease Ming Guo, Los Angeles, 
CA 
(Ganguly et al., 
2008) 
UAS-UBQLN1 ectopic
expression  
 
Alzheimer disease Ming Guo, Los Angeles 
CA 
(Ganguly et al., 
2008) 
UAS-UBQ-8i ectopic
expression  
 
Alzheimer disease Ming Guo, Los Angeles, 
CA 
(Ganguly et al., 
2008) 
UAS-ATX3-Q27  ectopic 
expression  
 
Spinocerebellar ataxia 3 John Warrick, 
Richmond VA 
 
(Warrick et al., 2005)
UAS-ATX3-trQ78 
(c37.3) 
ectopic 
expression  
 
Spinocerebellar ataxia John Warrick,
Richmond, VA 
 
(Warrick et al., 2005)
UAS-ATX3-trQ78 
(c211.2) 
ectopic 
expression  
 
Spinocerebellar ataxia John Warrick,
Richmond, VA 
 
(Warrick et al., 2005)
UAS-DJ-1β-RNAi 
17214  
knockdown Parkinson disease Vienna Drosophila 
RNAi Center 
(Dietzl et al., 2007) 
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UAS-DJ-1β-RNAi 
17215  
knockdown Parkinson disease Vienna Drosophila 
RNAi Center 
 
(Dietzl et al., 2007) 
UAS-DJ-1β  ectopic 
expression  
 
Parkinson disease Nancy Bonini, 
Philadelphia, PA 
 
(Meulener et al., 
2005) 
UAS-Pink1 L5  ectopic 
expression  
 
Parkinson disease Ming Guo, Los Angeles, 
CA 
(Clark et al., 2006) 
UAS-Pink1 L6  ectopic 
expression  
 
Parkinson disease Ming Guo, Los Angeles, 
CA 
(Clark et al., 2006) 
UAS-Parkin-RNAi 
47636 
knockdown Parkinson disease Vienna Drosophila 
RNAi Center 
 
(Dietzl et al., 2007) 
UAS-Parkin C2  
 
ectopic 
expression 
 
Parkinson disease Leo Pallanck, Seattle, 
WA 
(Greene et al., 2003) 
UAS-Sod1  ectopic 
expression 
 
Oxidative damage Gabriel Boulianne, 
Ontario, Canada 
 
(Parkes et al., 1998) 
UAS-Sod2-RNAi 
IR24  
knockdown Oxidative damage Vienna Drosophila 
RNAi Center 
 
(Dietzl et al., 2007) 
UAS-Sod1-RNAi 
31552  
knockdown Oxidative damage Vienna Drosophila 
RNAi Center 
 
(Dietzl et al., 2007) 
Atg1 mutant Autophagy Stock Collection,
Bloomington, IN 
 
 
Atg7 mutant Autophagy Stock Collection,
Bloomington, IN 
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UAS-Diap (2) ectopic 
expression 
 
Apoptosis Stock Collection,
Bloomington, IN 
 
 
UAS-Diap (3) ectopic 
expression 
 
Apoptosis Stock Collection,
Harvard, MA 
 
 
H99 mutant Apoptosis Herman Steller, New 
York, NY 
 
(White et al., 1994) 
Xr38 mutant Apoptosis Herman Steller, New 
York, NY 
 
(Peterson et al., 
2002) 
hidosmR8P mutant Apoptosis Herman Steller, New
York, NY  
(Grether et al., 1995) 
 
 
We pursued the potential interaction between wfs2 and PPT1 by performing a series of larger 
single-blind studies that included more than 300 eyes per genotype.  As previously reported 
(Korey and MacDonald, 2003), we found that overexpression of PPT1 via two independent 
transgenic lines (PPT1-2.1 and PPT1-8.1) in the fly eye led to a blackened ommatidia phenotype 
that exhibited variable expressivity (Figure 9A).  We characterized the phenotype in each eye as 
none (no black ommatidia), mild (a few black ommatidia), moderate (a patch of black 
ommatidia) or severe (black ommatidia throughout the eye) (Figure 9A i-iv, respectively).  We 
then compiled the data for each genotype so that the overall phenotype was represented in a 
histogram (Figure 9B-E).  This single-blind experimental design allowed us to formally compare 
the phenotypes between strains using logistical regression. 
 
These larger studies confirmed that wfs2 knockdown (via the WFS2.1 RNAi transgene) partially 
suppressed the black ommatidia phenotype caused by expression of two independent PPT1 
transgenes (Figure 9B, PPT1-2.1; Figure 9C, PPT1-8.1).  Similarly, knockdown of wfs2 via the 
WFS2.2 RNAi transgene led to a partial suppression of the black ommatidia phenotype in flies 
overexpressing PPT1 (Figure 9D, PPT1-2.1; Figure 9E, PPT1-8.1).  In all four combinations of 
wfs2 RNAi and PPT1 transgenes, the partial suppression of black ommatidia by wfs2 knockdown 
manifested as a leftward shift in the histograms (Figure 9B-9E; PPT1 overexpression alone, 
white bars; PPT1 overexpression with wfs2 knockdown, black bars).   
 
To address the possibility that expression of wfs2 RNAi transgenes suppressed the severity of  
black ommatidia simply by reducing the expression or function of PPT1, we performed qRT-
PCR to evaluate PPT1 mRNA expression and PPT1 enzyme assays to evaluate activity of PPT1.   
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Figure 9.  wfs2 RNAi in the eye suppresses the effects of PPT1 overexpression. (A) GMR-
Gal4-driven expression of two independent UAS-PPT1 transgenes (PPT1-2.1 and PPT1-8.1) 
caused black ommatidia that varied in severity.  Each eye was scored into one of four categories: 
none (i), mild (ii), moderate (iii) and severe (iv).  At least 300 eyes were assessed blind for each 
genotype.  (B-E) Expression of wfs2 RNAi suppressed the black ommatidia phenotype caused by 
PPT1 overexpression.  GMR-Gal4-driven expression of PPT1-2.1 alone or with WFS2.1 (B), 
PPT1-8.1 alone or with WFS2.1 (C), PPT1-2.1 alone or with WFS2.2 (D), and PPT1-8.1 alone or 
with WFS2.2 (E).  Data are the percentage of eyes in each category in PPT1 overexpressors 
(open bars) and PPT1 overexpression with wfs2 knockdown (closed bars).  In all cases the 
severity of the black ommatidia was decreased by expression of wfs2 RNAi (individual logistic 
regression, p<0.05, n = 310-801).  Data are compiled from two independent experiments.   
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We used fly head extracts for these studies because GMR-Gal4 drives expression in the eye (a 
major portion of the head) and therefore data from these extracts would be relevant for the eye 
phenotypes we characterized. Expression of wfs2 RNAi had no discernable effect on PPT1 
mRNA expression (Figure 10A).  Additionally, although expression of the WFS2.1 RNAi 
transgene led to a modest but statistically significant decrease in PPT1 enzyme activity (Figure 
10B), expression of the WFS2.2 RNAi transgene did not alter PPT1 enzyme activity.  Thus, co-
expression of the WFS2.1 and WFS2.2 RNAi transgenes did not consistently alter PPT1 enzyme 
activity.  The most parsimonious interpretation of our qRT-PCR and PPT1 enzyme studies is that 
the wfs2 RNAi-mediated suppression of black ommatidia is unlikely to be due to decreased 
expression or function of PPT1. Therefore, we conclude that the suppression of black ommatidia 
in PPT1 overexpressors is due to decreased function of wfs2.   
 
2.4 wfs2 genetically modifies a second lysosomal storage disease gene, CLN3 
Given that wfs2 is a genetic modifier of PPT1, a lysosomal storage disease gene, we postulated 
that wfs2 may interact with additional genes associated with lysosomal storage diseases.  To 
investigate this possibility, we assessed the effect of wfs2 knockdown on the external eye 
morphology of flies with altered expression of or mutations in genes associated with several 
different lysosomal storage diseases (Table 8).  In these studies knockdown of wfs2 appeared to 
enhance the small eye phenotype (Tuxworth et al. 2009) caused by CLN3 overexpression (Figure 
11A).  CLN3 is a transmembrane protein localized to the lysosomal membrane.  Mutations in 
CLN3 are responsible for the juvenile form of neuronal ceroid lipofuscinosis (JNCL), the most 
prevalent form of the neuronal ceroid lipofuscinosis diseases.   
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Figure 10:  Knockdown of wfs2 does not alter PPT1 mRNA expression or enzyme activity.  
GMR-Gal4 was used to drive UAS-PPT1 and UAS-wfs2 RNAi transgenes.   (A) PPT1 mRNA 
expression.  Total fly head mRNA was isolated from PPT1 overexpression flies with and without 
wfs2 RNAi.  PPT1 mRNA expression was measured by qRT-PCR.  wfs2 RNAi did not affect 
PPT1 mRNA expression levels (one-way ANOVA p>0.05).  Fold change of expression levels is 
relative to the GMR-Gal4/+ control.  (B and C) PPT1 enzyme activity in fly heads.  Fly heads 
were isolated from PPT1 overexpression flies with and without wfs2 RNAi.  PPT1 enzyme 
activity was measured as described in Methods.  (B) Co-expression of the WFS2.1 RNAi 
transgene with either PPT1-2.1 or PPT1-8.1 significantly decreased PPT1 enzyme activity, 
though the effect was small (Tukey HSD, p<0.05).  (C) Co-expression of the WFS2.2 RNAi 
transgene with either PPT1-2.1 or PPT1-8.1 did not affect PPT1 enzyme activity (Tukey HSD, 
n.s.) 
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Table 8. Lysosomal storage disease candidate interactors.  Each lysosomal storage disease strain (column 2) was  
Gene Allele or
Manipulation 
Class Source Citation
Benchwarmer P mutant Karen Schulze, Houston, TX (Dermaut et al., 2005) 
 P29 mutant Karen Schulze, Houston, TX (Dermaut et al., 2005) 
 E14.1 mutant Karen Schulze, Houston, TX (Dermaut et al., 2005) 
 ∆31 mutant Karen Schulze, Houston, TX (Dermaut et al., 2005) 
 ∆86 mutant 
 
Karen Schulze, Houston, TX 
 
(Dermaut et al., 2005) 
  
 
  
 
 
 
 
CG8596 
 
KG05284 P-element Stock Center, Bloomington, IN  
UAS-CG8596- knockdown Vienna Drosophila RNAi Center (Dietzl et al., 2007) 
UAS-CG8596-
 
knockdown
 
Vienna Drosophila RNAi Center 
 
(Dietzl et al., 2007) 
 
CLN3 UAS-CLN3- knockdown Vienna Drosophila RNAi Center (Dietzl et al., 2007) 
UAS-CLN3 ectopic Richard Tuxworth, London, UK (Tuxworth et al., 2009) 
crossed to flies expressing WFS2.1 RNAi in the eye via GMR-Gal4. 
 
 
Figure 11.  Knockdown of wfs2 enhances the small eye phenotype caused by CLN3 
overexpression.  (A) Light microscope images of GMR/+ control (i), CLN3/+ control (ii), 
GMR/CLN3 (iii), GMR-WFS2.1/CLN3 (iv), and GMR-WFS2.2/CLN3 (v).  (B) Quantitation of 
eye area in the indicated genotypes.  Area was measured from 5 eyes for each genotype.  Eye 
area was decreased in GMR/CLN3 flies (open bar) compared to controls (grey bars) (one-way 
ANOVA, p<0.0001; Tukey HSD, p<0.05).  Eye area was further decreased in GMR-
WFS2.1/CLN3 and GMR-WFS2.2/CLN3 flies (black bars) compared to GMR/CLN3 flies (open 
bar) (Tukey HSD, p<0.05).   (C) CLN3 mRNA expression.  Total fly head mRNA was isolated 
from flies overexpressing CLN3 alone or in conjunction with wfs2 RNAi.  CLN3 mRNA 
expression was measured by qRT-PCR.  CLN3 was robustly expressed in GMR/CLN3 and 
GMR/CLN3/WFS2.1 flies compared to GMR/+, CLN3/+ and GMR/WFS2.1 controls (one-way 
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ANOVA, p<0.02 Tukey HSD p<0.05, n = 3).  CLN3 induction was statistically indistinguishable 
in GMR/CLN3 (open bar) and GMR-WFS2.1/CLN3 flies (black bar) (Tukey HSD, n.s.).
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We pursued the potential interaction between wfs2 and CLN3 by performing additional 
experiments in which we measured the area of the eye using Scion image.  Consistent with the 
original description (Tuxworth et al., 2009), we found that CLN3 overexpression significantly 
reduced the size of the eye (Figure 11A and B).  We also found that expression of two 
independent wfs2 RNAi transgenes further reduced the size of the eye in flies with CLN3 
overexpression (Figure 11A and B).  In addition to small eye size, overexpression of CLN3 
causes a rough eye phenotype (Tuxworth et al., 2009), but this did not appear to be altered by 
wfs2 knockdown (Figure 11A).  To address whether the enhanced small eye phenotype could be 
due to increased CLN3 expression, we performed qRT-PCR studies on mRNA isolated from fly 
heads.  We found that wsf2 knockdown did not significantly alter CLN3 mRNA expression 
(Figure 11C).    These studies identify wfs2 as a genetic modifier of the CLN3 overexpression 
phenotype in flies. 
 
2.5 Knockdown of wfs2 does not interact with loss of function in PPT1 or CLN3 or with genetic 
modifiers of these genes 
Since reduced function of PPT1 or CLN3 alone does not cause obvious changes in external eye 
morphology (Hickey et al., 2006; Tuxworth et al., 2009), we postulated that wfs2 knockdown in 
conjunction with PPT1 or CLN3 loss of function might lead to a synthetic phenotype.  
Knockdown of wfs2 in the eye in PPT1 mutant or CLN3 knockdown flies, however, did not lead 
to an obvious change in the external morphology of the eye.  We also postulated that wfs2 may 
work in concert with previously identified genes that genetically interact with PPT1 and CLN3 
(Buff et al., 2007; Tuxworth et al., 2009).  We therefore evaluated the external eye morphology 
in flies harboring previously reported genetic modifiers of PPT1 and CLN3 (Table 9) alone and  
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Table 9.  Modifiers of PPT1 overexpression and CLN3 overexpression.  PPT1 modifiers were 
obtained from the Drosophila Stock Center (Bloomington, IN).  CLN3 modifiers were provided 
by Jennifer Treisman (Skirball Institute, NYU Medical Institute).   
 
Modifier for Gene Allele 
PPT1 overexpression Blue cheese EY02503
 ubcE2H EP1303 
 Fasciclin 2 EP1462 
 Fat facets EY02018
 Miniature EP406 
 Kayak EY00283
 Saxophone EY04377
 Fs(1)N EP1336 
 CG7023 EY00249
 CG5991 EY03559
 CG32138 EY03931
 CG18177 EP3301 
 CG5859 EP2090 
   
CLN3 overexpression Mago nashi 69B 
 Tsunagi ∆18 
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with wfs2 knockdown.  External eye morphology was normal in flies with PPT1 or CLN3 
modifiers with or without reduced wfs2.  These studies suggest that reduced function of wfs2 
does not interact with PPT1 or CLN3 loss of function manipulations or genetic modifiers of 
PPT1 or CLN3.  Our studies do not formally rule out these possibilities, however, since our 
interpretation is based on the lack of a synthetic phenotype. 
 
2.6 A novel interaction between PPT1 and CLN3 
PPT1 and CLN3 are the causative genes in two different lysosomal storage diseases in humans 
(Vesa et al., 1995; Munroe et al., 1997).  Our studies in flies indicate that both genes exhibit a 
genetic interaction with wfs2, suggesting that PPT1 and CLN3 may be functionally linked.  To 
address this possibility, we evaluated external eye morphology in flies expressing several 
different combinations of PPT1 and CLN3 transgenes.  We first asked whether overexpression of 
PPT1 could modify the phenotype of eyes with overexpression of CLN3.  Based on visual 
observation, we found no evidence that PPT1 overexpression altered the rough or small eye 
phenotypes due to CLN3 overexpression (Figure 12A).  Eyes with concurrent overexpression of 
both PPT1 and CLN3 did exhibit a decrease in pigmentation compared to eyes overexpressing 
either gene alone (Figure 12A).  Although this decrease in pigmentation is consistent with the 
possibility that PPT1 and CLN3 function in concert, it is also consistent with simple additive 
pathology.  Additionally, we found no evidence that PPT1 loss of function altered the rough or 
small eye phenotypes due to CLN3 overexpression (low pressure SEM, data not shown).  Thus, 
alteration of PPT1 expression does not appear to modify the effects of CLN3 overexpression in 
the Drosophila eye.   
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Figure 12. A genetic interaction between PPT1 and CLN3.  (A) Light microscope images of 
GMR/CLN3 (i), GMR PPT1-2.1, PPT1-8.1/+ (ii), and GMR PPT1-2.1, PPT1-8.1/CLN3 (iii). 
PPT1 overexpression did not alter the small or rough eye phenotypes caused by CLN3 
overexpression.  (B and C) Quantitation of black ommatidia due to PPT1 overexpression.  (B) 
CLN3 overexpression (black bars) suppressed the black ommatidia phenotype in PPT1 
overexpression flies (open bars) (logistic regression, p<0.05, n = 456-666  (C) Expression of 
CLN3 RNAi (black bars) enhanced the black ommatidia phenotype in PPT1 overexpression flies 
(open bars) (logistic regression, p<0.05, n = 579-666.  Data are the percentage of eyes in each 
category.  Data are compiled from two independent experiments. 
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We next addressed the possibility that CLN3 overexpression could modify the black ommatidia 
phenotype in eyes with PPT1 overexpression.  We used the same single-blind subjective 
quantitation of black ommatidia resulting in histograms as described for studies summarized in 
Figure 8.  Interestingly, we found that CLN3 overexpression partially suppressed the severity of 
black ommatidia caused by PPT1 overexpression (Figure 12B, leftward shift in black bars).  
Conversely, CLN3 knockdown via RNAi enhanced the severity of black ommatidia caused by 
PPT1 overexpression (Figure 12C, rightward shift in black bars).  These data indicate that CLN3 
modifies the PPT1 black ommatidia phenotype in Drosophila.  Furthermore, these data raise the 
possibility that CLN3 might normally function as a negative regulator of the PPT1 pathway.  
 
2.7 A model for the coordinated function of wfs2, PPT1 and CLN3 
Our data support a model in which wfs2, PPT1, and CLN3 function in concert (Figure 13).  In 
our model, wfs2 is normally a positive regulator of the pathway leading from PPT1 
overexpression to black ommatidia while it is normally a negative regulator of the pathway 
leading from CLN3 overexpression to reduced eye size.  Additionally, CLN3 normally 
antagonizes the PPT1 pathway leading to black ommatidia in our model.  Importantly, the 
arrows in our model (Figure 13) could represent a number of genes involved in the degenerative 
eye phenotypes caused by overexpression of PPT1 or CLN3.  Our studies are the first to support 
a model for the coordinated function of wfs2, PPT1 and CLN3 in any species. 
 
3. Discussion 
Wolfram syndrome is caused by mutations in WFS1 (Strom et al., 1998) and CISD2 (Amr et al., 
2007).  Although we are beginning to better understand the biochemical properties of the CISD2  
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Figure 13.  A proposed genetic model for wfs2, PPT1 and CLN3 function.  Overexpression of 
CLN3 and PPT1 led to eyes with reduced size or black ommatidia, respectively.  wfs2 is a 
negative regulator of the CLN3 pathway and is a positive regulator of the PPT1 pathway.  CLN3 
is a negative regulator of the PPT1 pathway.  As for the CLN3 small eye phenotype, alteration of 
PPT1 expression had no effect on the size of the eye suggesting that PPT1 functions upstream of 
CLN3.  Arrows in the model could represent the function of a number of genes and are not meant 
to indicate direct physical interactions between the gene products from CLN3, PPT1 or wfs2. 
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gene product (Amr et al., 2007), the genes and genetic pathways associated with CISD2 have not 
been characterized.  Here, we present the first genetic analysis of wfs2, the Drosophila 
orthologue to human CISD2. 
 
We used RNAi to knockdown expression of wfs2 and asked whether this manipulation led to 
obvious phenotypes in Drosophila.  Surprisingly, flies with strong loss of function in wfs2 alone 
appeared remarkably healthy under standard housing conditions and when subjected to various 
exogenous stressors.  While we do not currently understand why flies with wfs2 knockdown 
were seemingly unperturbed, several possibilities exist.  One possibility is that wfs2 knockdown 
could be deleterious only under prescribed environmental conditions such as in the presence of 
certain microbial pathogens as found in mouse models of cystic fibrosis (Davidson et al., 1995).  
Another possibility is that wfs2 has an important but very narrowly defined function in 
Drosophila.  Given these first two possibilities, it is conceivable that we have not examined the 
consequences of reduced wfs2 function under the required environmental conditions or that we 
simply have not performed the key set of experiments to assess the narrow function of wfs2.  
Another possibility is that there is a functionally redundant gene in flies that can compensate for 
reduced expression of wfs2.  Although it is difficult to formally exclude this possibility, wfs2 is 
the only CISD2 orthologue in flies and, importantly, reduced expression of wfs2 modifies PPT1 
and CLN3 pathology.  Thus, if there is a functionally redundant or compensatory gene in flies, it 
is not structurally homologous to wfs2 and it cannot compensate for reduced wfs2 expression in 
all experimental conditions.  A final possibility is that a low level of wfs2 expression, which 
could exist in our wfs2 knockdown flies, might be sufficient for supporting the functions that we 
have assessed.  This last possibility, if found to be true, would mirror findings with catalase loss 
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of function mutants in which 1% of wild-type expression is sufficient for viability under normal 
housing conditions (Mackay and Bewley, 1989).  While additional studies are required to more 
comprehensively address the effects of wfs2 loss of function in Drosophila, our results suggest 
that decreased expression of wfs2 alone does not have broad deleterious consequences in this 
organism.  Further assessment by placing wfs2 knockdown flies in different environments like 
excess cold or heat may trigger a physiological response that may result in detrimental 
phenotypes or sensitivity to stresses. 
 
Toward identifying genes that function in concert with wfs2, we determined whether knockdown 
of wfs2 modified the eye phenotype in several previously described models of neurodegeneration 
in Drosophila.  We found that knockdown of wfs2 suppresses the black ommatidia phenotype 
caused by PPT1 overexpression while it enhances the small eye phenotype caused by 
overexpression of CLN3 in flies.  Through follow-up studies we also found that altered CLN3 
expression modifies the severity of black ommatidia caused by PPT1 overexpression.  Our 
studies support a novel model in which wfs2, PPT1 and CLN3 function in concert. 
 
Mutations in PPT1 and CLN3 cause infantile neuronal ceroid lipofuscinosis (INCL) and juvenile 
neuronal ceroid lipofuscinosis (JNCL), respectively. Mutations in nine genes result in different 
forms of neuronal ceroid lipofuscinosis (NCL) with varying ages of onset (Mole, 2004).  All 
NCLs are characterized by progressive mental and motor deterioration, seizures, vision loss and 
premature death.  Additionally, all NCLs have characteristic inclusions in tissues due to the 
accumulation of substrates for these enzymes and are therefore classified as lysosomal storage 
diseases (Mitchison et al., 1998).  It would be interesting to determine whether Drosophila wfs2 
 84
interacts with lysosomal storage disease genes in addition to PPT1 and CLN3.  Furthermore, it 
would be interesting to explore whether CISD2 has comparable interactions with mammalian 
PPT1, CLN3 and potentially other lysosomal storage disease genes.  
 
Palmitoylation is a common post-translational protein modification that can affect protein 
localization, function, association with membranes, trafficking and activity (Smotrys and Linder, 
2004).  The PPT1 enzyme removes palmitoyl moieties from cysteine residues, thereby ensuring 
efficient degradation of de-palmitoylated proteins in the lysosome (Zeidman et al., 2009).  
Interestingly, the dWFS2 protein has a single predicted palmitoylation site on cysteine 60 (Figure 
7B).  This predicted palmitoylation site, however, is not found in the human ERIS protein.  
Furthermore, we could not find other predicted palmitoylation sites in human ERIS using CSS 
Palm 2.0 (Ren et al., 2008).  Although this suggests human ERIS is not palmitoylated, the 
absence of a consensus sequence for protein palmitoylation makes the prediction of 
palmitoylation sites difficult (Smotrys and Linder, 2004; Nadolski and Linder, 2007).  Future 
studies that examine whether ERIS is de-palmitoylated by PPT1 or other enzymes and, if so, 
whether the palmitoylation status of ERIS is linked to neurotoxicity could shed considerable 
light on the molecular basis for Wolfram Syndrome and possibly some lysosomal storage 
diseases. 
 
Mutations in CLN3 cause juvenile neuronal ceroid lipofuscinosis (JNCL), the most prevalent 
form of the NCLs. The clinical features of JNCL overlap with INCL except death occurs 
typically around the end of the second decade of life (Hofmann and Peltonen 2001).  CLN3 is a 
transmembrane protein localized to the lysosomal membrane.  Although the biochemical 
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function of CLN3 has not been fully resolved due to its hydrophobic nature (Rakheja et al., 
2008), it is predicted to participate in lysosomal pH homeostasis and to play a role in membrane 
trafficking through regulation of vesicle fusion and transport (Rakheja et al., 2008). Studies in  
Drosophila suggest that CLN3 might be involved in the Notch and JNK signaling pathways and 
in sphingolipid synthesis or trafficking (Persaud-Sawin et al., 2007; Tuxworth et al., 2009).  
Future studies that examine whether wfs2 is involved in sphingolipid metabolism or JNK 
signaling could provide insight into the normal biochemical function of wfs2 as well as Wolfram 
Syndrome pathology.   
 
Interestingly, CISD2 is predicted to function within the Beclin-1 mediated autophagy pathway 
(Chang et al., 2009).  It was determined that knock-down of CISD2 enhanced autophagy in 
starved cells (Chang et al., 2009).  During the process of autophagy, organelles and proteins are 
delivered to the lysosome for degradation which is accomplished through autophagosome-
lysosome fusion (Luzio et al., 2007).  There is evidence that disturbed autophagy is associated 
with lysosomal storage diseases (Kiselyov et al., 2007; Settembre et al., 2008).  Reduced 
autophagosome-lysosome fusion was determined to be a contributor to the neurodegeneration 
observed in a knock-in mouse model of JNCL (Cao et al., 2006).  Additionally, defective 
autophagocytic proteolysis was proposed to contribute to INCL pathology due to loss of PPT1 
function (Hofmann et al., 1997b).  Therefore, a relationship may exist between CISD2, 
alterations in autophagy and lysosomal storage diseases.  Future investigation into whether 
deficiency of CISD2 influences autophagy in the lysosomal storage diseases INCL and JNCL 
will provide insight into the role CISD2 has with regard to these and maybe other lysosomal 
storage diseases.   
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CLN3 overexpression suppresses the black ommatidia phenotype in PPT1 overexpressors 
whereas CLN3 loss of function enhances the black ommatidia phenotype.  These genetic 
interactions indicate that CLN3 and PPT1 might function in a common genetic pathway.  
Interestingly, CLN3 and PPT1 have been implicated in both sphingolipid metabolism (Persaud-
Sawin et al., 2007) and JNK signaling (Buff et al., 2007; Tuxworth et al., 2009), and disruption 
of sphingolipid metabolism and JNK signaling have been implicated in neurodegeneration 
(Kacher and Futerman, 2006; Johnson and Nakamura, 2007).  Thus, it is possible that changes in 
either sphingolipid metabolism or JNK signaling might be important for the CLN3- and PPT1-
induced degenerative phenotypes in flies.  Our studies provide the rational framework for 
investigating the connections between PPT1, CLN3, sphingolipid metabolism and JNK signaling 
within the context of neurodegeneration. 
 
Our studies in Drosophila reveal novel genetic interactions between wfs2, PPT1 and CLN3.  Our 
studies support several avenues of future research that could provide insight into molecular 
mechanisms associated with Wolfram Syndrome.  Additionally, our studies suggest that there 
could be previously unappreciated mechanistic connections between Wolfram Syndrome and 
lysosomal storage diseases. 
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Chapter 4 
 
Knockdown of DJ-1B and expression of wild-type Ataxin-3 suppresses the short lifespan in 
a Drosophila model of elevated endogenous oxidative stress 
 
 
1. Introduction 
 
Oxidative stress is caused by the imbalance between the production of prooxidants and 
antioxidant defense mechanisms.  Mitochondria are the major producers of superoxide, a reactive 
oxygen species (ROS) that is formed as a byproduct of cellular respiration (Fridovich, 2004).  
The generation of ROS from mitochondria is primarily determined by metabolic conditions, can 
be produced at high rates and is therefore mostly associated with damaging processes.  
Mitochondria consume more than 90% of cell O2 with at least 0.1% or more of O2 being reduced 
to superoxide (O2-) (Chance et al., 1979; Fridovich, 2004).  Redox reactions involving O2- 
generates other reactive oxygen species including the hydroxyl radical (OH-) that is highly 
reactive and results in oxidative damage to macromolecules (Chance et al., 1979).   
 
There are a number of antioxidant enzymes that protect cells from oxidative stress (Figure 14).  
Superoxide dismutase (SOD) enzymes catalyze the dismutation of superoxide to oxygen and 
hydrogen peroxide.  Hydrogen peroxide is subsequently reduced to water by catalase or a 
number of peroxidases (Halliwell B, 1999).  Peroxidases require an additional substrate that can 
be oxidized in concurrence with reduction of their ROS substrate (Matthews CK, 2000).  For 
example, the enzyme thioredoxin reductase (TrxR) reduces oxidized thioredoxin (TRx) so it can 
be used by thioredoxin peroxidase (TPx) (Missirlis et al., 2003).  Additionally, reduction of 
 88
 Figure 14.  The antioxidant enzymes (SOD, CAT, and TrxR) protect against oxidative 
stress.   See text for description of each antioxidant enzyme.
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peroxidized lipids is performed by phospholipid hydroperoxide glutathione peroxidase (PHGPx) 
(Conrad et al., 2007).  The two main superoxide dismutases in Drosophila are Sod1 that is  
located in the cytosol and Sod2 that is located in the mitochondrial matrix (Landis and Tower, 
2005).  Catalase, thioredoxin reductase and PHGpx are also conserved in Drosophila (Missirlis 
et al., 2001; Landis and Tower, 2005).  Therefore, Drosophila is a good model system to study 
antioxidant function (Missirlis et al., 2001). 
 
Complete loss or reduced functioning of antioxidant enzymes results in detrimental 
consequences to the organism.  For example, complete loss of SOD2 activity in mice results in a 
number of pathological conditions including dilated cardiomyopathy and motor disturbances 
with neurodegeneration (in a mixed C57BL/6 and 129Sv background), and a very short life span 
(Li et al., 1995; Lebovitz et al., 1996).  In Drosophila, knock-out or knockdown of Sod2 
throughout the body also severely shortens life span (Kirby et al., 2002; Duttaroy et al., 2003; 
Paul et al., 2007).  Furthermore, Sod2 deficient flies exhibit accelerated declines in locomotor 
behavior with age in addition to neurodegeneration and enhanced sensitivity to exogenous 
oxidative stress (Kirby et al., 2002; Bhandari et al., 2007; Paul et al., 2007).  Decreased SOD1 
activity in flies or mice also results in a shortened lifespan and detrimental phenotypes including 
sensitivity to exogenous oxidative stress and accelerated locomotor decline (Phillips et al., 1989; 
Muller et al., 2006; Martin et al., 2009a).  In addition, decreased functioning of catalase, PHGpx 
or TrxR in flies or mice is also associated with a decreased lifespan (Mackay and Bewley, 1989; 
Missirlis et al., 2001; Missirlis et al., 2002; Imai et al., 2003; Ho et al., 2004; Jakupoglu et al., 
2005).  All of these studies underscore the importance of antioxidant enzymes in protecting cells 
and tissues from oxidative stress.   
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Endogenous oxidative stress is associated with a number of age-related diseases including 
Parkinson disease, Friedrich ataxia, type 2 diabetes, cancer and neurodegeneration (McFarland et 
al., 2002; Schapira, 2006; McFarland et al., 2007).  For example, mutations in Ataxin-3 cause 
Spinocerebellar Ataxia 3 (SCA3). Expression of the pathogenic form of Ataxin-3 in cells resulted 
in decreased SOD and catalase activities (Yu et al., 2009).  Furthermore, post mortem samples 
from patients’ brains with Huntington disease have mitochondria with increased oxidative 
damage (Polidori et al., 1999).   Expression of the pathogenic form of huntingtin in cells also 
results in increased ROS production (Wyttenbach et al., 2002).  Therefore, oxidative stress 
appears to be a component of many age-related diseases. 
 
There are currently no reports on genetic manipulations that can compensate or alleviate the 
effects of decreased expression for any of the enzymes that function to remove ROS and reduce 
oxidative stress.  Drosophila Sod2 knockdown flies can serve as a model of endogenous 
oxidative stress and, therefore, can be used to identify genes that can reduce the negative 
consequences of endogenous oxidative stress.  Studies in this model may lead to a better 
understanding of the genetic mechanisms that influence the effects of endogenous oxidative 
stress.   
 
In this study we explored whether manipulation of a number of candidate genes could extend the 
short life span of Sod2 knockdown flies with the goal of identifying mechanisms that control or 
influence the negative consequences of enhanced endogenous oxidative stress.  Interestingly, we 
find that knockdown of DJ-1β, a fly ortholog of the Parkinson Disease-associated gene DJ-1, 
partially but reproducibly extends the life span of flies with ubiquitous knockdown of Sod2.  
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Additionally, we found that overexpression of human wild-type Ataxin-3 (46Q27) also 
reproducibly extends the short lifespan of flies with ubiquitous knockdown of Sod2.  Hence, 
reduced expression of DJ-1β or expression of human wild-type Ataxin-3 might ameliorate some 
of the detrimental effects of endogenous oxidative stress due to loss of Sod2 in flies.  Further 
study on how wild-type Ataxin-3 expression suppressed the short lifespan of Sod2 knockdown 
flies revealed that Ataxin-3 is protective only against some forms of exogenous oxidative stress.  
In addition, the ubiquitin-associated activity of Ataxin-3 is important for extending the short 
lifespan of Sod2 knockdown flies.  We also discovered that Ataxin-3 expression also partially 
restores the short lifespan due to muscle knockdown of another antioxidant enzyme thioredoxin 
reductase.  These studies support a protective role for reduced function of DJ-1β and expression 
of wild-type Ataxin-3 in ameliorating the short lifespan caused by endogenous oxidative stress 
due to loss of function of Sod2. 
 
2. Results 
 
2.1  Knockdown of DJ-1β and wild-type Ataxin-3 expression mitigates the short lifespan in     
Sod2 knockdown flies 
Knockdown of Sod2 in Drosophila via RNA interference (RNAi) using GAL4 to ubiquitously 
express a UAS-Sod2-inverted repeat (UAS-Sod2-IR) transgene substantially reduces SOD2 
enzymatic activity, shortens life span and results in sensitivity to the exogenous oxidative 
stressor paraquat (Kirby et al., 2002; Martin et al., 2009b).  Understanding how Sod2 works in 
concert with other genes to protect organisms from oxidative stress is a major unresolved issue.  
We addressed this by screening candidate genetic manipulations as potential modifiers of the 
short life span of Sod2 knockdown flies.  As a screening tool, we constructed via recombination 
a true-breeding stock of flies with Actin-Gal4 and Sod2-IR15 on the same chromosome (Actin-
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Gal4::Sod2-IR15) and with da-Gal4 and Sod2-IR15 on the same chromosome (da-Gal4::Sod2-
IR15).  Actin-Gal4 and da-Gal4 drives expression ubiquitously (Wairkar et al., 2008). Ubiquitous 
knockdown of Sod2 via the da-Gal4 driver decreases median lifespan by 79% and ubiquitous 
knockdown of Sod2 via the Actin-Gal4 driver decreases median lifespan by 88%, respectively 
(Martin et al., 2009b).  These stocks are maintained by constantly transferring progeny to new 
bottles every two weeks. 
 
We initiated our screen by assessing life span in the F1 progeny of Actin-Gal4::Sod2-IR15 flies 
crossed to a series of candidate mutations or UAS transgenes (Table 10).  Given the profound 
life span reduction resulting from loss of Sod2, we reasoned that manipulation of any single 
genetic modifier would likely have only partial effects on the life span of Sod2 knockdown flies.  
This candidate approach identified that expression of two independent UAS-DJ-1β inverted 
repeat (UAS-DJ-1β-IR) transgenes reproducibly extended the median life span of Sod2 
knockdown flies by more than 50% (Figure 15).  We performed a series of qRT-PCR analyses to 
address a number of questions related to the functionality of the UAS-DJ-1β-IR transgenes. 
Expression of DJ-1β-IR by Actin-Gal4 substantially knocked down endogenous DJ-1β 
expression in flies with a normal complement of Sod2 and in Sod2 knockdown flies (Figure  
16A).  Additionally, expression of DJ-1β-IR did not significantly alter the expression of the 
related gene DJ-1α (Figure 16B).  Knockdown of Sod2 expression (Figure 16C) and SOD2 
enzymatic activity (Figure 16D) by Sod2-IR were not significantly altered by concurrent 
expression of DJ-1β-IR.  These studies indicate that DJ-1β-IR selectively knocks down DJ-1β 
and does not interfere with the ability of Sod2-IR to knockdown Sod2.  Loss of function 
mutations in PARK7 which encodes DJ-1 causes a rare form of autosomal recessive early-onset 
Parkinson Disease (Bonifati et al., 2003).  
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Table 10: Representative candidate suppressors tested for the effect on the short lifespan of 
Sod2 knockdown flies.  A brief function (column 2) is listed for each of the candidate 
suppressors (column 1).  A total of 76 candidate suppressors were assessed.  Effect (column 3) 
refers to whether the candidate suppressors are gain or loss of function manipulations. 
 
Candidate Suppressor Function Effect
H99 (rpr, hid, grim) apoptosis loss 
hid[0514 8D] apoptosis loss 
rpr[X38] apoptosis loss 
UAS-dIAP-1 apoptosis gain 
UAS-dIAP-2 apoptosis gain 
UAS-dIAP-3 apoptosis gain 
UAS-p35 BH1 apoptosis gain 
UAS-p35 BH2 apoptosis gain 
UAS-p35 BH3 apoptosis gain 
UAS-CG11337-IR1 apoptosis, other loss 
UAS-CG11337-IR2 apoptosis, other loss 
UAS-p53 apoptosis, other gain 
UAS-p53.1 apoptosis, other gain 
UAS-p53.2 apoptosis, other gain 
UAS-p53.H159N-2 apoptosis, other loss 
UAS-p53.R155H-2 apoptosis, other loss 
UAS-p53-2.1 apoptosis, other gain 
UAS-p53H159N-3 apoptosis, other loss 
Atg1 autophagy loss 
Atg7 autophagy loss 
Hsp22[EP3247] chaperone gain 
Hsp22[EY09909] chaperone gain 
UAS-hHSP70/CyO chaperone gain 
UAS-hHSP70-dHSP40 chaperone gain 
UAS-HSC 70.3 chaperone gain 
UAS-HSC 70.4 chaperone gain 
UAS-HSP40/CyO chaperone gain 
UAS-GFP control (GFP) gain 
UAS-lacZ control (lacZ) gain 
Pfrx[BG02836] delayed aging-gluconeogenesis loss 
Pfrx[KG02298] delayed aging-gluconeogenesis loss 
Akt[c02098] delayed aging-insulin signaling loss 
Akt[EY1002] delayed aging-insulin signaling loss 
Dp110[e03435] delayed aging-insulin signaling loss 
PDK1[EP837] delayed aging-insulin signaling loss 
PDK1[ex12] delayed aging-insulin signaling loss 
PDK1[ex7] delayed aging-insulin signaling loss 
PDK1[ex8] delayed aging-insulin signaling loss 
Excl[1174] delayed aging-Rho gap loss 
Doc3[708] delayed aging-Tbox transcription gain 
Ant2[G0083] mitochondrial ATP synthesis loss 
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sesB[EP1577] mitochondrial ATP synthesis loss 
SesB[G0126] mitochondrial ATP synthesis loss 
sesB[G0386] mitochondrial ATP synthesis loss 
sesB[KG04431] mitochondrial ATP synthesis loss 
Kdn[vf] mitochondrial citrate synthase loss 
UAS-Park-C2 mitochondrial fission gain 
UAS-PINK1-L5 mitochondrial fission gain 
UAS-PINK1-L6 mitochondrial fission gain 
Opa1-like[f02279] mitochondrial fusion loss 
Opa1-like[S3475] mitochondrial fusion loss 
tko[25t] mitochondrial translation loss 
UAS-hUCP2 mitochondrial uncoupling protein gain 
porin f03616 mitochondrial VDAC loss 
porin K05123 mitochondrial VDAC loss 
UAS-sniffer oxidative stress, carbonyl reductase gain 
UAS-catalase oxidative stress, catalase gain 
mt-catalase oxidative stress, catalase (mito-targeted) gain 
mt-catalase oxidative stress, catalase (mito-targeted) gain 
Cat-Sod1-TR-1 oxidative stress, catalase, Sod1, thioredoxin reductase gain 
Cat-Sod1-TR-2 oxidative stress, catalase, Sod1, thioredoxin reductase gain 
Cat-Sod1-TR-3 oxidative stress, catalase, Sod1, thioredoxin reductase gain 
Cat-Sod1-TR-4 oxidative stress, catalase, Sod1, thioredoxin reductase gain 
UAS-DJ-1alpha IR oxidative stress, DJ-1alpha loss 
UAS-DJ-1beta oxidative stress, DJ-1beta gain 
UAS-DJ-1beta IR-1 oxidative stress, DJ-1beta loss 
UAS-DJ-1beta IR-2 oxidative stress, DJ-1beta loss 
UAS-GCLc-5 oxidative stress, glutamate-cysteine ligase (catalytic) gain 
UAS-GCLc-6 oxidative stress, glutamate-cysteine ligase (catalytic) gain 
UAS-GCLm-2 oxidative stress, glutamate-cysteine ligase (modulatory) gain 
UAS-GCLm-3 oxidative stress, glutamate-cysteine ligase (modulatory) gain 
UAS-GSH Px oxidative stress, glutathione peroxidase gain 
UAS-MSRA(C) oxidative stress, methionine sulfoxide reductase A gain 
UAS-Sod1 oxidative stress, SOD1 gain 
UAS-DTS-5-11 proteosome loss 
UAS-46Q27 (WT Ataxin-3) ubiquitination gain 
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Figure 15. DJ-1β knockdown partially restores life span in Sod2 knockdown flies. 
Expression of two independent UAS-DJ-1βIR transgenes (1 and 2) extended the life span of 
Actin-Gal4::Sod2-IR15 flies (log-rank test, p<0.0001, n = 210-248 flies per genotype from 2 
experiments).  Median life span was increased by 57%.  Experiments were performed by Ian 
Martin. 
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Figure 16.  DJ-1β  RNAi reduces DJ-1β  expression and has no effect on Sod2 expression or 
enzyme activity. Quantitative real-time PCR was performed as described in materials and 
methods using PCR primers listed in Table 4. (A) Ubiquitous expression of UAS-DJ-1β-IR 
transgenes in Actin-Gal4;DJ-1β-IR and Actin-Gal4::Sod2-IR15;DJ-1β-IR flies significantly 
reduced DJ-1β  expression relative to controls containing DJ-1β-IR alone (one-way ANOVA, p 
< 0.0001, n = 3 groups of 25 flies per genotype, followed by Bonferroni’s post-test, * p < 0.05). 
Bonferroni’s post-test also revealed no significant difference in the extent of DJ-1β  knockdown 
in Actin-Gal4::Sod2-IR15;DJ-1β-IR relative to Actin-Gal4; DJ-1β-IR flies. DJ-1β RNAi had no 
significant effect on expression of DJ-1α  (one-way ANOVA, not significant, n = 3 groups of 25 
flies per genotype) (B) or Sod2 (one-way ANOVA, not significant, n = 3 groups of 25 flies per 
genotype). (D) Activities of SOD2 or SOD1 were unaffected by expression of DJ-1β-IR 
(individual one-way ANOVAs, not significant, n = 3).  SOD activity performed by Ian Martin. 
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Additionally, our candidate approach identified that ubiquitous expression of human wild-type 
Ataxin-3 using the Actin-Gal4 or da-Gal4 driver also reproducibly extended the median life span 
of Sod2 knockdown flies by more than 50% (Figure 17A and B).  qRT-PCR analysis revealed 
that Ataxin-3 was robustly expressed via the da-Gal4 driver in flies with a normal complement of 
Sod2 and in Sod2 knockdown flies (Figure 18A).  Furthermore, Ataxin-3 expression did not 
significantly alter knockdown of Sod2 expression or SOD2 enzymatic activity (Figure 18B and 
C).  These studies indicate that Ataxin-3 is robustly expressed and does not interfere with the 
ability of Sod2-IR to knockdown Sod2.  Mutations in the gene Ataxin-3 result in Spinocerebellar 
Ataxia 3 a.k.a. Machado Joseph disease (MJD), a progressive neurodegenerative disorder 
(Takiyama et al., 1993).  Given that wild-type Ataxin-3 expression has demonstrated protective 
effects in neurodegenerative disease models in Drosophila (Warrick et al. 2005), we 
consequently decided to focus on the ability of Ataxin-3 expression to suppress the short lifespan 
of Sod2 knockdown flies.  
 
2.2 Ataxin-3 expression enhances H2O2 resistance of Sod2 knockdown flies 
To investigate how wild-type Ataxin-3 expression suppresses the short lifespan of Sod2 
knockdown flies, we determined whether wild-type Ataxin-3 expression could suppress the 
sensitivity of Sod2 knockdown flies to various exogenous oxidative stresses (paraquat, hyperoxia 
and H2O2).  As expected, Sod2 knockdown flies were sensitive to all three stressors compared to 
controls (Figure 19).  Interestingly, wild-type Ataxin-3 expression enhanced resistance of Sod2 
knockdown flies to H2O2 but not to paraquat and hyperoxia (Figure 19).  We also determined 
that wild-type Ataxin-3 expression (da-Gal4/ATX3) alone in Drosophila does not enhance 
resistance against any of these exogenous oxidative stressors, suggesting that expression of wild-
type Ataxin-3 has no protective effect on its own (Figure 19).  These results suggest that wild- 
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 Figure 17.  Ataxin-3 expression partially restores life span in Sod2 knockdown flies.  (A) 
Expression of the human wild-type Ataxin-3 extends the life span of Actin-Gal4::Sod2-IR15 flies 
(log-rank test, p<.0001 n = 100 flies per genotype from two experiments).  Median life span was 
increased by 52%. (B) Expression of Ataxin-3 extends the life span of da-Gal4::Sod2-IR15 flies 
(log-rank test, p<.0001  n = 100 flies per genotype from two experiments).  Median life span was 
increased by 100%.  Experiments were performed by Devin Rhodenizer. 
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Figure 18.  Expression of Ataxin-3 does not alter Sod2 expression or enzyme activity.    (A) 
qRT-PCR analysis of Ataxin-3 expression.  Ataxin-3 expression is not significantly altered by 
Sod2 knockdown (one-way ANOVA, p<0.001, n=3; *Bonferroni’s multiple comparison test, 
p<0.05).  Data are representative of 3 independent experiments.  (B) qRT-PCR analysis of Sod2 
expression.  Knockdown of Sod2 mRNA via the da-Gal4 driver is not altered by Ataxin-3 
expression (Compare last two columns, one-way ANOVA, p<0.001, n=3; *Bonferroni’s multiple 
comparison test, p<0.05). (C) Activities of SOD2 or SOD1 were unaffected by expression of 
Ataxin-3 (individual one-way ANOVAs, not significant, n = 3).  SOD activity performed by 
Devin Rhodenizer. 
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Figure 19.  Ataxin-3 expression enhances resistance of Sod2 knockdown flies to H2O2 but 
not to paraquat and hyperoxia.  Survival in the presence of paraquat (A), hyperoxia (B) and 
H2O2 (C).  Survival in the presence of paraquat or hyperoxia was decreased in Sod2 knockdown 
flies (da-Gal4-Sod2IR/+) and in Sod2 knockdown flies with Ataxin-3 (da-Gal4-Sod2IR/ATX3) 
expression compared to controls with normal levels of Sod2 (da-Gal4/+, da-Gal4/ATX3, 
Sod2IR/ATX3) (one-way ANOVA p<0.001, n=3; *Bonferroni’s multiple comparison test, 
p>0.05).  Survival in the presence of H2O2 was enhanced in Sod2 knockdown flies with Ataxin-3 
expression compared to flies with Sod2 knockdown alone (one-way ANOVA p<0.001, n=3; 
*Bonferroni’s multiple comparison test, p<0.001).   
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type Ataxin-3 expression can enhance resistance to some but not all forms of exogenous 
oxidative stress in a Sod2 deficient background. 
 
2.3 The ubiquitin-associated function of Ataxin-3 is important for extending the short lifespan of 
Sod2 knockdown flies  
One of the main functions of the proteasome is to remove oxidatively damaged proteins 
(Ciechanover, 2005). One of the main predicted functions of Ataxin-3 is to support the transport 
of ubiquitinated proteins to the proteasome for degradation (Doss-Pepe et al., 2003) suggesting 
Ataxin-3 facilitates in the degradation of oxidatively damaged proteins.  Ataxin-3 contains a 
ubiquitin protease domain and several ubiquitin interacting motifs located near the polyQ repeat 
(Thrower et al., 2000; Burnett et al., 2003).   To investigate whether the ubiquitin-associated 
function of Ataxin-3 is important for extending the short lifespan of Sod2 knockdown flies we 
obtained Drosophila UAS-transgenes that have a mutation in the ubiquitin protease domain 
(UPD) or the ubiquitin interacting motifs (UIM) in Ataxin-3.  These transgenes are not 
pathogenic but they do abolish ubiquitin protease activity and prevent ubiquitin binding, 
respectively (Warrick et al., 2005).  We postulated that abolishing the ubiquitin-associated 
activities of Ataxin-3 would prevent its ability to extend the short lifespan of Sod2 knockdown 
flies.  Therefore, we evaluated lifespan in Sod2 knockdown flies and in Sod2 knockdown flies 
with each Ataxin-3 mutant using the ubiquitous da-Gal4 driver and the muscle 24B-Gal4 driver.  
Expression of Ataxin-3 with the UPD mutated failed to extend the short lifespan of Sod2 
knockdown flies (Figure 20A and B).  Expression of Ataxin-3 with the UIM mutated failed to 
fully extend the short lifespan of Sod2 knockdown flies.  Ataxin-3 to extend the short lifespan of  
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Figure 20. The ubiquitin-associated function of Ataxin-3 is important for extending the 
short lifespan of Sod2 knockdown flies.   Survival under normal housing conditions using the 
ubiquitous da-Gal4 driver (A) and muscle 24B-Gal4 driver (B).  Expression of Ataxin-3 (da-
Gal4-Sod2IR/ATX3, 24B-Gal4-Sod2IR/ATX3) and Ataxin-3 with the ubiquitin interacting motif 
(UIM) mutated (da-Gal4-Sod2IR/UIM, 24B-Gal4-Sod2IR/UIM) partially extends the short 
lifespan of Sod2 knockdown flies. (log-rank test, p<.0001 n = 175 flies per genotype from one 
experiment).  Expression of Ataxin-3 with the ubiquitin protease domain (UPD) mutated (da-
Gal4-Sod2IR/UPD, 24B-Gal4-Sod2IR/UPD) does not extend the short lifespan of ubiquitous or 
muscle knockdown of Sod2. (C) Light microscope images of ATX3-TRQ78/+ (i), ATX3-
TRQ78/ATX3 (ii), ATX3-TRQ78/UPD (iii), ATX3-TRQ78/UIM (iv).  Ataxin-3 expression 
suppresses the degenerative eye phenotype of pathogenic ATX3-TRQ78 flies (compare ii with i).  
Ataxin-3 with the ubiquitin protease domain mutated fails to suppress the degenerative eye 
phenotype of pathogenic ATX3-TRQ78 flies (compare iii with i).  Ataxin-3 with the ubiquitin 
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interacting motif mutated partially suppresses the degenerative eye phenotype of pathogenic 
ATX3-TRQ78 flies (compare iv with i). 
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Sod2 knockdown flies (Figure 20A and B).  The effects of the UPD and UIM mutants on the 
short lifespan of Sod2 knockdown flies is similar to what was observed when these mutants were 
expressed in the eye for a pathogenic fly model of SCA3 (Figure 20C) (Warrick et al., 2005).  
Therefore, these results suggest that the ubiquitin-associated activities, especially the ubiquitin 
protease function of wild-type Ataxin-3 is important in extending the short lifespan of Sod2 
knockdown flies.   
 
2.4  Ataxin-3 expression mitigates the short lifespan in thioredoxin reductase knockdown flies 
We showed that expression of wild-type Ataxin-3 suppresses (i.e. extends) the short lifespan of 
Sod2 knockdown flies (Figure 15).  We extended these data by determining whether wild-type 
Ataxin-3 expression could also suppress the short lifespan due to knockdown of other antioxidant 
related genes in flies.  To investigate this we obtained a number of RNAi transgenic strains from 
the Vienna Drosophila Research Center (VDRC) for a number of antioxidant related genes in 
Drosophila including thioredoxin reductase, catalase, PHGpx, and a DNA damage repair gene 
RpS3.  We first investigated whether lifespan was altered in these RNAi transgenic strains when 
expressed ubiquitously via the da-Gal4 driver or in muscle via the mef2- Gal4 driver.  We 
determined that flies with knockdown of RpS3 ubiquitously or in muscle were lethal (Table 11).  
Flies with ubiquitous knockdown of thioredoxin reductase were also lethal (Table 11). 
Additionally, flies with ubiquitous knockdown of Sod1, ubiquitous or muscle knockdown of 
PHGpx and flies with muscle knockdown of thioredoxin reductase were short-lived (Table 11).  
We consequently decided to focus on the RNAi strains that resulted in lethality or severely 
reduced lifespan when expressed ubiquitously or in muscle which included thioredoxin 
reductase, PHGpx, and RpS3.   
 
 105
Table 11:  Median lifespan of antioxidant related and DNA repair RNAi strains.  RNAi 
strains (column 1) and median lifespan via the ubiquitous da-Gal4 driver (column 2) and the 
muscle specific mef2-Gal4 driver (column 3).  Median lifespan in a wild-type fly ~50 days. 
 
RNAi strain da-Gal4  Mef2-Gal4 
Sod1 F103 15 >30 
Sod1 31551 36 >30 
Sod1 31552 12 >30 
Trxr 47306 Lethal  12 
Trxr 47307 Lethal 6 
Trxr 47308 Lethal 6 
Catalase 6283 30 >30 
Catalase 103591 >60 >30 
PHGpx 100790 7 6 
RpS3 37741 Lethal Lethal 
RpS3 37742 Lethal Lethal 
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To determine whether expression of wild-type Ataxin-3 could extend the short lifespan or rescue 
the lethality in these knockdown strains we expressed wild-type Ataxin-3 in flies with concurrent  
ubiquitous or muscle knockdown of PHGpx, RpS3 and thioredoxin reductase.  Expression of 
Ataxin-3 did not rescue the lethality caused by ubiquitous knockdown of thioredoxin reductase or 
the lethality caused by ubiquitous or muscle knockdown of RpS3.  Additionally, expression of 
Ataxin-3 had no consistent effect on the short lifespan caused by ubiquitous or muscle 
knockdown of PHGpx (Figure 21A and B).  Interestingly, Ataxin-3 expression reproducibly 
extended the short lifespan caused by muscle knockdown of thioredoxin reductase (Figure 21C).  
These results suggest that Ataxin-3 expression is protective against partial loss of function of 
thioredoxin reductase.  Furthermore, these results support the possibility that Ataxin-3 might play 
a broader role in protecting against endogenous oxidative stress. 
 
3. Discussion 
Sod2 is a critical antioxidant localized to the mitochondria (Landis and Tower, 2005).  Whole-
body loss of Sod2 function through RNAi-mediated silencing or knock-out of the endogenous 
Sod2 gene, dramatically shortens life span and causes behavioral defects in flies (Kirby et al., 
2002; Duttaroy et al., 2003; Bhandari et al., 2007; Paul et al., 2007), and mice (Li et al., 1995; 
Lebovitz et al., 1996).  The identification of genes that work in concert with Sod2 is a critical 
step toward understanding mechanisms related to endogenous oxidative stress.  We used Sod2 
knockdown flies as a model of elevated endogenous oxidative stress to search for genetic 
manipulations that can modify the deleterious consequences of Sod2 knockdown on life span. 
Through a candidate approach, we found that RNAi-mediated knockdown of DJ-1β partially, but 
reproducibly, mitigated the effect of Sod2 knockdown on life span.  Importantly, DJ-1β  
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Figure 21.  Wild-type Ataxin-3 expression only extends the short lifespan caused by 
knockdown of thioredoxin reductase in muscle.  Ubiquitous (da-Gal4) or muscle (mef2-Gal4) 
knockdown of PHGpx results in a shortened lifespan (A and B).  Expression of Ataxin-3 fails to 
rescue the short lifespan in these animals (log-rank test, n.s. n = 175 flies per genotype from two 
experiments) (A and B). Knockdown of thioredoxin reductase in muscle results in a shortened 
lifespan (C).  Expression of Ataxin-3 extends the short lifespan caused by knockdown of 
thioredoxin reductase in muscle (C) (log-rank test, p<.0001 n = 175 flies per genotype from two 
experiments). 
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knockdown does not alter knockdown of Sod2 expression, the activity of SOD2 or SOD1, or 
expression of the related gene DJ-1α.  Loss of function mutants of DJ-1β results in a shortened 
lifespan in Drosophila (Lavara-Culebras and Paricio, 2007) so the effect of extending the short 
lifespan of Sod2 knockdown flies is specific to Sod2. 
 
Loss of function mutations in DJ-1 cause autosomal recessive early-onset Parkinson Disease 
(Bonifati et al., 2003). Although the biochemical role of DJ-1 has not been fully resolved, DJ-1 
has been characterized as an atypical peroxiredoxin-like peroxidase (Andres-Mateos et al., 2007) 
that also acts as a regulator of gene expression (van der Brug et al., 2008) and a molecular 
chaperone (Zhou et al., 2006).  Together, our studies point toward a surprisingly complex 
relationship between Sod2, DJ-1 and oxidative stress.  One possible explanation for this 
relationship is that DJ-1β knockdown may cause compensatory changes in antioxidants or repair 
enzymes that partially protect against mitochondrial oxidative stress related to the loss of Sod2.  
Another possibility is that concomitant knockdown of Sod2 and DJ-1β together could result in 
synergistic changes in the expression of antioxidants or repair enzymes that partially compensate 
for the loss of Sod2.  It is also possible that DJ-1β may be an oxidative stress signaling molecule 
that triggers apoptosis and that partial loss of function of DJ-1β allows cells to survive, hence 
extending the short lifespan of Sod2 knockdown flies.  Evidence for a possible signaling role is 
provided by evidence of a signaling event in two other genes associated with Parkinson disease.  
Mutations in the genes Pink1 and Parkin cause recessive forms of familial Parkinson Disease.  
There is evidence that these genes are involved in a mitochondrial turnover pathway.  For 
example, Pink1 accumulates on damaged mitochondria and Pink1 recruits Parkin to these 
mitochondria (Narendra et al., 2009).  Parkin then promotes the degradation of these 
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dysfunctional mitochondria (Narendra et al., 2009).  Therefore, Pink1 and Parkin selectively 
promote the degradation of damaged mitochondria (Narendra et al., 2009).  It is possible that DJ-
1β could also be involved in this mitochondrial turnover pathway.  Additionally, redox signaling 
might underlie the short life span of Sod2 knockdown flies.  For example, if Sod2 knockdown 
flies are placed under hypoxia, their lifespan is fully restored (Wicks et al., 2009).  Furthermore, 
placing Sod2 knockdown flies into a hypoxia environment after 50% mortality causes the 
remaining surviving flies to live as long as flies permanently placed under hypoxia (Wicks et al., 
2009).  This suggests that a redox signaling mechanism might be involved in the rapid reversal 
of mortality when flies are placed under a hypoxic environment.  Additional studies will be 
important for determining whether DJ-1β is part of a signaling pathway that senses oxidative 
damage and leads to the removal of dysfunctional mitochondria.  It will also be interesting to 
determine whether reduced DJ-1β expression can ameliorate additional negative consequences 
associated with loss of Sod2 including enhanced locomotor impairment and enhanced sensitivity 
to exogenous oxidative stress.  
 
Our candidate approach also found that wild-type Ataxin-3 expression partially, but 
reproducibly, mitigated the effect of Sod2 knockdown on life span.  Ataxin-3 expression did not 
alter knockdown of Sod2 expression, or the activity of SOD2 or SOD1.  Wild-type Ataxin-3 
expression is reported to have no effect on lifespan when expressed in Drosophila (Warrick et 
al., 2005) suggesting the extension of lifespan with Sod2 knockdown is specific to Sod2.  
Mutations in Ataxin-3 cause Spinocerebellar Ataxia 3, a polyglutamine repeat disease with more 
than 50 repeats needed for clinical representation of this disorder (Gusella and MacDonald, 
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2000).  An expanded polyQ repeat in Ataxin-3 causes misfolding and aggregation resulting in a 
toxic gain of function property of the protein (La Spada et al., 1994).   
 
Ataxin-3 is a protease that is thought to remove ubiquitin from proteins (Burnett et al., 2003). 
Ataxin-3 also assists in targeting proteins to the proteasome (Wang et al., 2006b).  In addition to 
Ataxin-3, the human genome contains ~100 other deubiquitinating enzymes (Nijman et al., 
2005).  There is evidence that wild-type Ataxin-3 may play a protective role against 
neurodegenerative disease.  Interestingly, Ataxin-3 was localized in the nuclear inclusions in 
patients with SCA3 and amyotrophic lateral sclerosis (Fujigasaki et al., 2000; Seilhean et al., 
2004).  The presence of nuclear inclusions are believed to represent  protection or repair attempts 
of the cell and the presence of Ataxin-3 in these nuclear inclusions supports the role of this 
protein in conferring protective properties (Arrasate et al., 2004).  Additionally, expression of 
wild-type Ataxin-3 in Drosophila suppresses the neurodegenerative eye phenotype for several 
neurodegenerative disease models including SCA3, SCA1 and Huntington disease (Warrick et 
al., 2005).  The extension of the short lifespan of Sod2 knockdown flies further suggests that 
Ataxin-3 confers protective properties.  To this end we investigated how Ataxin-3 suppressed the 
short lifespan of Sod2 knockdown flies.   
 
Our studies demonstrated that although expression of Ataxin-3 in a wild type genetic background 
did not enhance resistance to the exogenous oxidative stressors paraquat, hyperoxia and H2O2, it 
did enhance resistance to H2O2 stress in an elevated endogenous oxidative stress background via 
Sod2 knockdown.  The resistance to only one exogenous oxidative stressor could be due to each 
stressor having different effects on cells and the organism as a whole. For example, paraquat 
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generates reactive oxygen species (superoxide anion and hydroxyl radical) that can damage cells 
and also depletes cellular reducing equivalents including NADPH that are needed for normal 
cellular function  (Bus and Gibson, 1984).  In contrast, H2O2 can alter the overall redox potential 
of the cell and can stimulate growth arrest and cell death (Stone and Yang, 2006).   We conclude 
that expression of Ataxin-3 does not provide an overall protection against exogenous oxidative 
stress.  
 
We determined the ubiquitin-associated function of Ataxin-3 is important for suppressing the 
short lifespan of Sod2 knockdown flies.  It is possible that the ubiquitin-associated function of 
Ataxin-3 enhances the activity of the proteasome to remove oxidatively damaged proteins.  
Increased and more efficient removal of oxidatively damaged proteins could have a protective 
effect that would allow the Sod2 knockdown flies to live longer.  It would be interesting to 
determine whether expression of other genes involved in ubiquitin proteasome function 
including faf and other ubiquitin proteases (Wu et al., 1999; DiAntonio et al., 2001) or 
enhancement of ubiquitin dependent pathways could also extend the short lifespan of Sod2 
knockdown flies.  Further investigation into whether enhanced expression of other 
deubiquitinating enzymes in Drosophila extend the short lifespan of Sod2 knockdown flies will 
provide insight into a possible mechanism that may protect against endogenous oxidative stress.   
 
Interestingly, we also determined that Ataxin-3 expression can partially rescue the short lifespan 
due to knockdown of another antioxidant enzyme thioredoxin reductase in the muscle.  This 
suggests that Ataxin-3 expression may be protective against the short lifespan associated with 
endogenous oxidative stress due to reduction of two antioxidant related genes in flies.  Further 
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study using the Ataxin-3 UPD and UIM transgenes will provide insight into whether the 
ubiquitin-associated function of Ataxin-3 is important for extending the short lifespan due to 
muscle knockdown of thioredoxin reductase.  It would be interesting to determine whether 
expression of Ataxin-3 in mice with Sod2 knockdown improves survival in these mice due to loss 
of function of Sod2.   It would also be interesting to determine whether enhanced expression of 
Ataxin-3 can rescue the lethality in mice with inactivation of thioredoxin reductase.  Additional 
studies to determine whether Ataxin-3 can ameliorate other negative consequences associated 
with elevated endogenous oxidative stress will provide insight into whether Ataxin-3 expression 
has protective effects across many physiological parameters.  For example, Ataxin-3 expression 
may forestall the accelerated ARLI that is observed in Sod2 knockdown flies.  Ataxin-3 
expression may also lower the amount of apoptosis present in Sod2 knockdown flies and can be 
measured via a caspase assay.  This has implications for the development of possible therapies 
that could either delay the onset or prevent the detrimental phenotypes associated with 
endogenous oxidative stress. 
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Chapter 5 
Summary 
 
This dissertation comprises research using Drosophila as a model to investigate the mechanisms 
associated with aging and age-related disease.  Each independent project resulted in the 
elucidation of different mechanisms involved in non pathological and pathological aging.  The 
following summarizes the findings from each project culminating with a discussion regarding 
future studies.   
 
Age- related locomotor impairment (ARLI) is a significant challenge to the elderly and their 
caretakers.  ARLI is associated with a decrease in mobility, increased fear of falling, increased 
risk of skeletal fractures and increased mortality.  A better understanding of genes and genetic 
pathways that forestall ARLI has implications for the development of interventions that can lead 
to an improved quality of life for the elderly.  Through a forward genetic screen the lab identified 
a partial loss of function mutation in PDK1 with delayed ARLI.  Further study revealed that loss 
of function mutants in additional insulin signaling genes resulted in delayed ARLI.  These results 
support the involvement of the insulin signaling pathway as a process that influences ARLI.  
This pathway is conserved across species thereby making any discoveries using model organisms 
likely applicable to humans.  It would be interesting to determine whether loss of function 
mutations or polymorphisms within the insulin signaling pathway components in mice or 
humans also delay ARLI.   Identification of key tissues where insulin signaling is important for 
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regulating ARLI can provide insight into whether reduced insulin signaling in certain tissues is 
required for the beneficial effects on locomotor decline across age.  For example, muscle and 
neuron Gal4 drivers can be used to express insulin signaling genes in these tissues and these 
manipulation can be evaluated for locomotor impairment across age.  Additional studies to 
identify cellular changes or changes in patterns of gene expression across age via microarray 
analysis in these insulin signaling mutants will provide additional information into how reduced 
insulin signaling delays ARLI. 
 
Wolfram Syndrome is a progressive neurodegenerative disease.  The function of the more 
recently identified gene CISD2 has not been fully resolved.  Additionally, the genes that interact 
with CISD2 or the pathway this gene resides in have yet to be identified.  Drosophila contains 
one ortholog of CISD2 that we have named wfs2.  We used RNAi to knockdown wfs2 to provide 
further insight into the function of this gene.  A targeted genetic screen in the eye was performed 
to identify genes that interact with wfs2.  Two genes were identified through this screen.  We 
found that knockdown of wfs2 suppresses the black ommatidia phenotype caused by PPT1 
overexpression.  In contrast wfs2 knockdown enhances the small eye phenotype caused by 
overexpression of CLN3.  Loss of function mutations in the genes PPT1 and CLN3 cause two 
forms of neuronal ceroid lipofuscinosis (NCL).  The NCL diseases are pediatric 
neurodegenerative disorders and are classified as lysosomal storage diseases.  We are the first to 
identify genes that interact with Drosophila wfs2.  We believe that wfs2 and these lysosomal 
storage diseases may share common molecular-genetic mechanisms.  We also believe wfs2 plays 
a role in the degenerative pathways associated with these lysosomal storage diseases.  It will be 
imperative to demonstrate that PPT1 and CLN3 interact with wfs2 in mammalian systems to 
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confirm that these interactions are conserved in higher organisms.  It will also be interesting to 
determine whether knockdown of wfs2 interacts with other known lysosomal storage disease 
genes in Drosophila and if these potential interactions are observed in higher organisms.  
Furthermore, studies to identify additional genes that interact with wfs2 will further elucidate 
which pathway wfs2 resides in.  A greater understanding of the function of wfs2 and what 
pathway wfs2 resides in has implications for the management and treatment of patients with 
Wolfram Syndrome.   
 
Oxidative stress is associated with aging and age-related diseases.  Antioxidant enzymes function 
to decrease the amount of oxidative stress on the organism.  Reduced functioning of antioxidant 
enzymes is reported to decrease lifespan and causes other detrimental consequences.  It is 
currently unknown what genes or mechanisms protect from endogenous oxidative stress caused 
by loss of function of antioxidant enzymes.  Therefore, the lab performed a candidate suppressor 
screen to identify genes that can serve a protective role against a model of endogenous oxidative 
stress via Sod2 knockdown.  Our screen identified that knockdown of DJ-1β and expression of 
human wild-type Ataxin-3 both partially extended the short lifespan due to ubiquitous 
knockdown of Sod2.  The ability of DJ-1β to mitigate the short lifespan of Sod2 knockdown flies 
suggests that either DJ-1β influences other antioxidant related enzymes or this gene could be 
involved in signaling to the cell that oxidative damage is present.  We further probed how 
Ataxin-3 expression mitigated the short lifespan of Sod2 knockdown flies and determined that 
the ubiquitin associated function of Ataxin-3 is important for extending the short lifespan.  
Additionally, we determined that Ataxin-3 expression can also partially extend the short lifespan 
caused by knockdown of thioredoxin reductase in muscle.  Ataxin-3 is a deubiquitinating enzyme 
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and is involved in transporting ubiquitinated proteins to the proteasome for degradation.  
Therefore, expression of Ataxin-3 in Drosophila may improve the removal of ubiquitin chains 
thereby allowing the proteasome to effectively degrade more oxidatively damaged proteins.  
These results suggest the function of deubiquitinating enzymes or genes involved in the 
ubiquitin-proteasome pathway may be very important in the regulation of removing oxidatively 
damaged proteins in diseases where oxidative stress is a component.  Dysfunction of the 
ubiquitin-proteasome pathway is associated with a number of neurodegenerative diseases which 
further supports this hypothesis.  It will be important to demonstrate that overexpression of 
Ataxin-3 in mice deficient in Sod2 or thioredoxin reductase can rescue the short lifespan or 
lethality observed in these animals.  It would be interesting to determine if enhanced expression 
of deubiquitinating enzymes in Drosophila or genes involved in the ubiquitin proteasome 
pathway also extend the short lifespan of Sod2 knockdown flies.   
 
One possible connection with all three projects is with oxidative stress.  Elevated endogenous 
oxidative stress has been implicated in ARLI and in neurodegenerative disease.  Whether 
enhanced oxidative stress resistance is a requirement for delayed ARLI or whether oxidative 
stress could be a component to Wolfram Syndrome pathology is discussed below. 
 
The lab determined that elevated endogenous oxidative stress influences ARLI.  Sod2 
knockdown flies serve as a model of endogenous oxidative stress.  Testing of the Sod2 
knockdown flies in the RING assay revealed that these flies have accelerated ARLI.  
Furthermore, oxidative stress is implicated in ARLI in rodents and may also be associated with 
ARLI in humans.  We therefore investigated whether there was a connection between oxidative 
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stress resistance and a delay in ARLI.  An increase in lifespan is correlated with an increased 
resistance to exogenous oxidative stress.  Therefore an increase in exogenous oxidative stress 
resistance may also be correlated with delayed ARLI.  This seemed feasible when the seven 
delayed ARLI mutants recovered from the forward genetic screen were all discovered to be 
resistant to the exogenous oxidative stressor paraquat.  However, further analysis of additional 
insulin signaling mutants with delayed ARLI revealed that most of these strains were not 
resistant to paraquat.  These results suggest that an enhanced resistance to exogenous oxidative 
stress is not required for delayed ARLI in Drosophila.  Unlike lifespan, a delay in ARLI can be 
uncoupled from oxidative stress resistance.  Therefore, mechanisms independent of enhanced 
resistance to exogenous oxidative stress contribute to the delayed ARLI observed in these insulin 
signaling mutants.  Further analysis will reveal mechanisms that contribute to a delay in ARLI.  
For example, it would be interesting to determine whether enhanced immune function is 
important for delayed ARLI.  Flies that are resistant to bacterial infection may have forestalled 
ARLI.   
 
Oxidative stress is reported to be implicated in several neurodegenerative diseases including 
Parkinson, Alzheimer, and Huntington disease.  A component of Wolfram Syndrome is 
progressive neurodegeneration.  Many of the tissues involved in this disease have a high 
metabolic demand suggesting that mitochondrial dysfunction may be a component to Wolfram 
Syndrome.  It is currently unclear whether oxidative stress contributes to the progressive 
neurodegeneration observed in Wolfram Syndrome patients.  A knock-out mouse model of 
CISD2 observed mitochondrial dysfunction in these mice.  However, there was no significant 
difference in the levels of reactive oxygen species (ROS) in several cell lines including MEFs, 
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primary cortex, and primary hepatocytes in 12 week old Cisd2 knock-out mice compared to 
controls.. Furthermore, no significant difference in the expression of enzymes that scavenge ROS 
including SOD1, SOD2, and catalase were identified in brain, heart, liver, and skeletal muscle 
tissue in 12 week old Cisd2 knock-out mice compared to controls.  We also investigated whether 
oxidative stress could be a component to Wolfram Syndrome.  Knockdown of wfs2 in flies did 
not result in sensitivity to a number of exogenous oxidative stresses compared to controls at 1 or 
6 weeks of age.  Ubiquitous knockdown of wfs2 also did not have a significant difference in 
Sod2 expression levels at either 1 or 6 weeks of age compared to controls.  These results support 
the hypothesis that oxidative stress may not be a component of Wolfram Syndrome pathology.  
In contrast, knockdown of CISD2 in insulinoma cell lines increased the expression of the 
antioxidant enzymes SOD1 and SOD2.  These cell lines also had an increase in nitrated tyrosines 
which is indicative of an oxidative stress response (Sami Amr, personal communication).  These 
findings suggest oxidative stress may be a component of Wolfram Syndrome pathology.  
Therefore, it is still unclear as to whether oxidative stress is implicated in Wolfram Syndrome.  
However, it is possible that evaluation of ROS production or expression levels of the antioxidant 
enzymes in certain key tissues will reveal an oxidative stress component.  Further study is 
required in cellular and animal models to identify whether oxidative stress contributes to the 
degenerative phenotypes associated with Wolfram Syndrome.    
 
The mechanisms associated with non pathological and pathological aging appear to be different 
in ARLI, Wolfram Syndrome and in a model of endogenous oxidative stress.  Drosophila is a 
very powerful model organism to identify mechanisms associated with both aging and age-
related disease.  A better understanding of which specific mechanisms are associated with a 
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delayed ARLI, further elucidation of which genes interact with wfs2 and the pathway this gene 
resides in, and the mechanisms involved for Ataxin-3 to suppress the short lifespan of Sod2 
knockdown flies will provide insight into common or distinct genetic and cellular changes 
associated with non pathological and pathological aging.  The discoveries in this dissertation 
research may provide a framework for further investigation that may aid in the development of 
interventions, management, therapy, or treatment options for humans afflicted with ARLI, 
Wolfram Syndrome, and in age-related diseases where oxidative stress is a component.    
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Appendix: 
 
Knock-down of wfs2 does not cause detrimental effects in Drosophila 
 
 
 
 
Figure A1.  Knockdown of wfs2 does not effect locomotor behavior across age.  (A) 
Ubiquitous knockdown of wfs2 (Actin-Gal4/WFS2.1) did not alter locomotor performance 
(negative geotaxis) across age compared to controls (Actin-Gal4/+, WFS2.1/+) (two-way 
ANOVA, n.s.)  (B) Muscle knockdown of wfs2 (mef2-Gal4/WFS2.1) did not alter locomotor 
performance (negative geotaxis) across age compared to controls (mef2-Gal4/+, WFS2.1/+)  (C 
and D)  Nervous system knockdown of wfs2 (188Y-Gal4/WFS2.1, appl-Gal4/WFS2.1) did not 
alter locomotor performance (negative geotaxis) across age compared to controls (188Y-Gal4/+, 
appl-Gal4/+, WFS2.1/+). 
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Figure A2.  Knockdown of wfs2 has no consistent effect on lifespan.  (A) Survival under 
normal housing conditions in males was not altered by ubiquitous expression of WFS2.1 RNAi 
(actin-Gal4/WFS2.1) compared to controls (WFS2.1/+, actin-Gal4/+).  (B) Survival in males was 
not altered with muscle expression of WFS2.1 RNAi (mef2-Gal4/WFS2.1) compared to controls 
(WFS2.1/+, mef2-Gal4/+).  (C and D) Survival in males was not altered with nervous system 
expression of WFS2.1 RNAi (188Y-Gal4/WFS2.1 and appl-Gal4/WFS2.1) compared to controls 
(WFS2.1/+, 188Y-Gal4/+, appl-Gal4/+). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 139
 
Figure A3.  Knockdown of wfs2 does not cause sensitivity to various stresses.  (A and B) 
Ubiquitous knockdown of wfs2 in flies at week 1 (A) and week 6 (B) of age did not alter survival 
under desiccation stress compared to controls (da-Gal4/+, WFS2.1/+).  (C and D) Ubiquitous 
knockdown of wfs2 in flies at week 1 (C) and week 6 (D) of age did not alter survival under 
starvation stress compared to controls (da-Gal4/+, WFS2.1/+). (E and F) Ubiquitous knockdown 
of wfs2 in flies at week 1 (E) and week 6 (F) of age did not alter survival under paraquat stress 
compared to controls (da-Gal4/+, WFS2.1/+).  (G) Ubiquitous knockdown of wfs2 in flies at 
week 6 of age did not alter survival under thermal stress compared to controls (da-Gal4/+, 
WFS2.1/+). 
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Figure A4.  wfs2 knockdown does not cause sensitivity to various exogenous stresses.  (A 
and B) Ubiquitous (A) and nervous system (B) knockdown of wfs2 in flies at 1 week of age did 
not alter survival under FeCL3 stress compared to controls (da-Gal4/+, WFS2.1/+).  (C and D)  
Ubiquitous (C) and nervous system (D) knockdown of wfs2 in flies at 1 week of age did not alter 
survival under H2O2 stress compared to controls (da-Gal4/+, WFS2.1/+).  (E and F) Ubiquitous 
(E) and nervous system (F) knockdown of wfs2 in flies at 6 weeks of age did not alter survival 
under hyperoxia stress compared to controls (da-Gal4/+, WFS2.1/+). 
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Figure A5.  wfs2 knockdown does not cause sensitivity to ER stress at 1 week of age.  (A and 
B) Survival in males was not altered by ubiquitous expression of WFS2.1 RNAi (actin-
Gal4/WFS2.1, da-Gal4/WFS2.1) compared to controls (WFS2.1/+, actin-Gal4/+, da-Gal4/+).  (C 
and D)  Survival in males was not altered by nervous system expression of WFS2.1 RNAi 
(188Y-Gal4/WFS2.1, appl-Gal4/WFS2.1) compared to controls (WFS2.1/+, 188Y-Gal4/+, appl-
Gal4/+).  (E) Survival in males was not altered by muscle expression of WFS2.1 RNAi (mef2-
Gal4/WFS2.1) compared to controls (WFS2.1/+, mef2-Gal4/+,).   
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Figure A6.  wfs2 knockdown does not cause sensitivity to ER stress at 3 weeks of age.  (A 
and B) Survival in males was not altered by ubiquitous expression of WFS2.1 RNAi (actin-
Gal4/WFS2.1, da-Gal4/WFS2.1) compared to controls (WFS2.1/+, actin-Gal4/+, da-Gal4/+).  (C 
and D)  Survival in males was not altered by nervous system expression of WFS2.1 RNAi 
(188Y-Gal4/WFS2.1, appl-Gal4/WFS2.1) compared to controls (WFS2.1/+, 188Y-Gal4/+, appl-
Gal4/+).  (E) Survival in males was not altered by muscle expression of WFS2.1 RNAi (mef2-
Gal4/WFS2.1) compared to controls (WFS2.1/+, mef2-Gal4/+,).   
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Figure A7.  wfs2 knockdown does not cause sensitivity to ER stress at 6 weeks of age.  (A 
and B) Survival in males was not altered by ubiquitous expression of WFS2.1 RNAi (actin-
Gal4/WFS2.1, da-Gal4/WFS2.1) compared to controls (WFS2.1/+, actin-Gal4/+, da-Gal4/+).  (C 
and D)  Survival in males was not altered by nervous system expression of WFS2.1 RNAi 
(188Y-Gal4/WFS2.1, appl-Gal4/WFS2.1) compared to controls (WFS2.1/+, 188Y-Gal4/+, appl-
Gal4/+).  (E) Survival in males was not altered by muscle expression of WFS2.1 RNAi (mef2-
Gal4/WFS2.1) compared to controls (WFS2.1/+, mef2-Gal4/+,).   
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